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Abstract  
 
The aim of this research is to assess the in-vitro antiproliferative activities of the crude 
extract, preparative HPLC fractions and pure active compounds in selected 
Palestinian plants, namely Cuscuta palaestina, Gundelia tournefortii, Pimpinella 
anisum and Ephedra alata. Chromatographic and spectroscopic techniques such as 
analytical HPLC-PDA, preparative HPLC-PDA, GC-MS, 
1
H-NMR, and LC-MS and 
biological assays were used to achieve this goal. 
Cuscuta palaestina is listed as native plant of flora palaestina. The methanolic and 
hexane extracts were used to determine its activity against human colorectal 
carcinoma cell line. The in-vitro results using MTT and the LDH leakage assays, gave 
EC50 values of 71.55 ± 4.75 µg/ml for methanol extract and 175.21 ± 3.89 µg/ml for 
hexane extract. The methanolic extract exerted a significant anti-proliferative effect 
on the HCT-116 cancer cell line. Sesamin and two other Phytosterols namely 
Campesterol and Stigmasterol, have been identified in this plant and therefore could 
be the major source for their anticancer activity. The Sesamin percentage in the 
methanolic extract is found to be three times more than Sesame seeds.  
Gundelia tournefortii is an Artichoke-like edible wild thistle is commonly used in 
Palestinian Cuisine. Its anticancer effects on the Human colon carcinoma cell line was 
investigated. Methanol and hexane extracts were found to exert considerable 
antitumor activity against HCT-116 cancer cell line with EC50 values of 303.3 ± 12 
µg/ml, 313.3 ± 18.6 µg/ml respectively, while the aqueous extract was inactive. 
Phytochemical identities in both methanol and hexane extracts using GC-MS revealed 
about seventy compounds. Six potential compounds are β-Sitosterol, Stigmasterol, 
Lupeol, Gitoxigenin, α-Amyrin and Artemisinin. Eight fractions were collected by 
preparative-HPLC and tested in-vitro. The cytotoxic effect of fraction VIII was found 
to be the highest against HCT-116 cancer cell line.  
Pimpinella anisum L. (Anise) was found to have potential anticancer activity on 
human prostate cancer cell line (PC-3). Six fractions of anise methanolic extract were 
collected using preparative-HPLC. The obtained EC50 value as measured for fractions 
II, III, IV, and V by the MTT assay was 0.5 ± 0.10 mg/ml, 0.3 ± 0.11 mg/ml, 0.49 ± 
0.12 mg/ml, 0.23 ± 0.10 mg/ml, respectively.  
III 
 
Ephedra alata acquired recently a tremendous reputation after the use of its stems to 
heal a Palestinian farmer from Jenin. The in vitro antiprolliferative activity of its 
methanolic extract gave EC50 value of 25 ± 1.2 µg/ml by using MTT assay against 
HepG2 cell line (human liver cancer). 
Therefore, the four investigated Palestinian plants could be further investigated to 
reach new anticancer lead or drug and to study mechanism of action and evaluate 
efficiency and toxicity for in vivo models. 
 
 
Keywords: Cytotoxicity, Cuscuta palaestina, antiproliferation, anticancer, HCT-116 
(human colon cancer cell line); MTT, LDH, EC50, GC-MS analysis. Gundelia 
tournefortii, phytochemicals, Pimpinella Anisum, Anise PC-3 (human Prostate cancer 
cell line); Ephedra alata HepG2 (human liver cancer cell line);  
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1. Introduction 
1.1. Cancer diseases and their therapy  
Cancer is the second leading cause of death in the world after cardiovascular disease. 
Every year, more than 8.2 million cancer deaths are reported worldwide. The 14.1 
million new cases each year, were 32.5 million persons are alive with cancer. It is 
about 68% occurring in the developing countries alone. WHO predicts 23.6 million 
cases in the year 2030s [1,2].  
Cancer is uncontrolled dividing and growth of the abnormal cell due to their internal 
factors (inherited genetic mutations, hormones, immune conditions), and external 
factors (unhealthy diet, chemicals, radiation, viruses, lifestyle), and environmental 
change (smoking, air pollution, sunlight, work place like UV radiation). Cancer cells, 
which are already irreversibly developed, have the capability to escape apoptosis by a 
number of ways that involve transformation, dysregulation of apoptosis, proliferation, 
invasion, angiogenesis and metastasis. Extensive research during the last 35 years has 
revealed much about the biology of cancer. While the normal body cells grow, 
dividing, and die in an orderly fashion. Mutations in certain genes, mainly in proto-
oncogenes, and tumor-suppressor genes, can contribute to the development of cancer 
[3]. 
There are many types of cancers infect humans like lung, breast, prostate, ovarian, 
bladder, neck, blood, colorectal, stomach, esophageal, pancreatic, liver, brain cancer, 
and other neoplasm. Cancer is a complex disease involving numerous temporospatial 
changes in cell physiology, which ultimately lead to malignant tumors. Abnormal cell 
growth (neoplasia) is the biological endpoint of the disease. Tumor cell invasion of 
surrounding tissues and distant organs is the primary cause of morbidity and mortality 
for most cancer patients. The biological process by which normal cells are 
transformed into malignant cancer cells has been the subject of a large research effort 
in the biomedical sciences for many decades. Despite this research effort, cures or 
long term management strategies for metastatic cancer are as challenging today as 
they were 44 years ago when President Richard Nixon declared a war on cancer [4,5]. 
When cancer spreads to other parts of the body, this is called metastasis. Metastases 
can occur when cancer cells enter the blood stream or lymph system, these systems 
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circulate all over the body and allow the cells to travel to another part of the body, 
which increases the seriousness of the disease [6]. 
 
There are four main types of cancer: 
1) Carcinomas – cancers of the organs.  
2) Sarcomas – cancers of the muscles, bone, cartilage, and connective tissue.  
3) Lymphomas – cancers of the lymphatic system. 
4) Leukemia's – cancers of the blood-making system. 
Fig. 1 shows the estimated cancer mortality worldwide in 2012 [7]. 
Fig. 1: Estimated cancer mortality for both sexes worldwide in 2012. 
 
Each year, the American Cancer Society for example estimates the numbers of new 
cancer cases and deaths that will occur in the United States in the current year and 
compiles the most recent data on cancer incidence, mortality, and survival. Fig. 2 
shows the leading 10 types of cancer estimates in the US at 2015 [8]. 
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Fig. 2: Ten leading cancer types for the estimated new cancer cases and deaths by sex, United 
States, 2015. 
 
Depending on the type of cancer, age of patient, sex of patient (male or female), 
tumor location, and stage, there are many option of treatment of cancer, which include 
Surgery, Radiation therapy, Chemotherapy, Immunotherapy, Hormone therapy, 
targeted therapy, and also extracts or leads from herbal medicine.  
 
1.2. Secondary metabolites from natural product  
In the simplest terms, natural product is a molecule that is produced from plants, 
animal, microbes, micro-organism [9]. The primary metabolites, in contrast, such as 
acyl lipids, nucleotides, amino acids, and organic acids, are found in all plants and 
perform metabolic roles that are essential and usually evident [10]. While the 
secondary metabolite facilitates the primary metabolism in plants contain a huge 
amount of compounds that are not strictly necessary for growth and development, but 
which play a crucial role in defense mechanism and adaption to the environment, 
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which include terpenes, phytosterols, steroids, phenolics and alkaloids, exhibit a wide 
range of biological activities and have immense potential application in the chemical-
pharmaceutical industries as pharmaceuticals, agrochemicals, flavors, fragrances, 
colors, biopesticides, and food additives [11]. Phytochemicals are the active 
secondary metabolite components, present in a plant that account for its medicinal 
properties. As a central theme of exploration bordering chemistry and biology, natural 
products research focuses on the chemical properties, structures, chromatographic 
isolation, biosynthesis and biological functions of active secondary metabolites. 
Lignans for example are large class of secondary metabolites in plants, with numerous 
biological effect in mammals, including antitumor and antioxidant activities. Sesamin 
specifically is the most abundant furofuran-class lignan in sesame seeds. Recently, 
sesame cytochrome P450, CYP81Q1, as the first P450 enzyme responsible for lignan 
biosynthesis has been identified [12]. Pinoresinol is synthesized by the stereospecific 
coupling of two units of achiral E -coniferyl alcohol in the presence of a dirigent 
protein (DIR). CYP81Q1 converts pinoresinol to sesamin via piperitol, and has been 
designated piperitol/sesamin synthase (PPS) as shown in Fig. 3.   
 
 
 
Fig. 3: Lignan biosynthesis pathways for sesamin. DIR, dirigent protein; PSS, 
piperitol/sesamin synthase.  
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The major sterol is typically sitosterol, followed by campesterol, stigmasterol, and 
various minor sterols. Sitosterol and stigmasterol play crucial roles in cellular 
membranes, especially in the plasma membrane. Campesterol is the precursor to the 
brassinosteroids (BRs), the only plant steroid hormones identified thus far. Signaling 
roles for additional plant steroid compounds are not known thus far (Fig. 4). 
 
 
Fig. 4: Biosynthesis of important phytosterols 
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1.3. Medicinal plants and traditional medicine 
Throughout history, man used various natural materials as a remedy for various 
diseases. In the past few decades, most natural products were replaced with synthetic 
drugs that were based on modern chemistry and biotechnology between 1990s and 
1997 in the U.S.A. However, we are recently witnessing a vastly growing and 
renewed interest in natural medicines in western countries. In particular, the herbal 
medicine market has distributed and became prosperous in pharmacies and many 
stores [13]. Medicinal plants are commercially available, cheaper, as compared to 
modern drugs. Thus, the various combinations of the active components of these 
plants after chromatographic isolation and spectroscopic identification can be made 
and may be further assessed for their synergistic effects. The bioactive compounds 
have a tangible effect on the living organism, tissue or cell [14]. 
Recent years have witnessed a renewed interest in plants as an alternative avenue to 
discover new pharmaceuticals during 1990s to now. This interest is driven by both 
academia and pharmaceutical industry and has led to the espousal of crude extracts of 
plants for self-medication by the general public. Plants used in traditional medicine; 
therefore, have an important role to play in the maintenance of health worldwide, and 
in the introduction of new treatments [15,16].  
More than 60 percent of the currently used anticancer agent are derived in one way or 
another from natural sources, including plants [17,18]. WHO estimates that up to 80 
percent of the world’s population relies on herbal medicine for some aspect of 
primary health care [19]. 
Herbal medicine has been universally accepted and has had a great impact on the 
worlds of health and international trade [20]. However, screening medicinal plants in 
in vitro systems is the first step in finding potential anticancer compounds [21]. 
Where estimated number of plant species on earth ranges between 500,000 and 
1,250,000 and less than 10 percent of these have been studied chemically and 
pharmacologically for their potential medicinal value [22]. 
In Palestine, traditional remedies are usually part of its culture and religious life. , Still 
however few herbal products used in folk medicine were investigated and recorded.It 
has a rich and prestigious heritage of herbal medicines; in addition more than 700 
species of medicinal plant are known to exist, and approximately 63 of these are 
activity used for the preparation of traditional medicines [23]. Medicinal plants in 
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Palestine as well as in other developing countries has high pharmaceutical and 
ecological value, and have important elements of indigenous medical systems [24,25].  
 
1.4. Natural products used as anticancer agent, isolation and 
identification 
The terrestrial plants remain important source of new chemical entity to treatment of 
cancer in clinical trials. There are many classes of plant-derived cytotoxic natural 
products against cancer cells, and studied for further improvement and development 
of anticancer agent. For example, Vincristine, irinotecan, etoposide, paclitaxel, 
Viniblastine, and Camptothecin. Since the oceans cover more than 70% of the earth 
surface, and the marine environment is highly diverse, marine organisms would be 
also a wonderful source of biologically active anticancer molecules. For example, 
aplidine, didemin, dolastatin, citarabine, homophymines, jaspamide, and from micro-
organisms like, dactinomycin, bleomycin and doxorubicin. Examples of the 
biomolecules responsible for the anticancer activity microbial sources are such as 
dactinomycin, bleomycin, and doxorubicin [26,27,28]. 
Besides, this there is numerous agents from fruits and vegetables that can be used in 
anticancer therapy. The agents include curcumin (turmeric), resveratrol (red grapes, 
peanuts and berries), genistein (soybean), diallyl sulfide (allium), S-allyl cysteine 
(allium), allicin (garlic), lycopene (tomato), capsaicin (red chilli), diosgenin 
(fenugreek), 6-gingerol (ginger), ellagic acid (pomegranate), ursolic acid (apple, 
pears, prunes), silymarin (milk thistle), anethol (anise, camphor, and fennel), 
catechins (green tea), eugenol (cloves), indole-3-carbinol (cruciferous vegetables), 
limonene (citrus fruits), beta carotene (carrots) [29]. 
Isolation of secondary metabolite from higher plants (leaves, flowers, stems, seeds or 
fruits) are examples of natural bioactive compounds from potential sources as 
flavonoids and essential oil, and testing for biological activity has to be done after a 
purification process. The active agent can be isolated depends on the, stability, and 
quantity of extract in the plant natural product in order to fully elucidate the structure 
of the active compounds [30]. The majority of isolation procedures still utilize simple 
extraction procedures with organic solvents of different polarity using infusion or by 
sonication [31,32]. Other methods include Soxhlet extraction which is a popular 
method due to its reduced solvent consumption; however, thermo-labile compounds 
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might be degraded during the extraction process. For liquid samples, extraction by 
organic solvents or heterogeneous solvent mixtures can be used, either simply in a 
separating funnel or similar to a Soxhlet apparatus in a perforator [33]. 
Chromatographic techniques utilized gas chromatography (GC) and High-
Performance Liquid Chromatography (HPLC). Hyphenation of HPLC with different 
spectroscopic detectors like Mass Spectrometry (MS), Photodiode array (PDA) and 
Evaporative Light Scattering Detector (ELSD) are available techniques. Proton 
Nuclear Magnetic Resonance (
1
H-NMR), Carbon-13 Nuclear Magnetic Resonance 
(
13
C-NMR) and 2D-NMR spectroscopy offers ways to identification of plant material. 
Preparative HPLC is an excellent technique used for fractionation and isolation of 
pure active compounds with high peak resolution power and selectivity. In case of 
analyzing biological material containing volatile constituents like essential oils, GC-
MS analysis still represents the method of choice, taking advantage of the 
unsurpassed peak capacity of capillary GC columns. Electron impact mode is usually 
used and there are libraries such as NIST which contains about half million 
compounds for matching the compounds identity. Headspace solid-phase micro-
extraction (SPME) or steam distillation (SD) extraction methods can be used to 
collect the volatile fractions from small amounts of plant material [34].  
 
1.5. Screening anticancer bioactivity from four Palestinian plants 
1.5.1. Cuscuta palaestina plant 
The first plant that we will extract it and scan its anticancer activity is called Cuscuta 
palaestina. It is a plant that belongs to Cuscuta species, and Convolvulaceae family. It 
is an extensive climber parasitic plant that more often called “dodder” in English and 
Halook or Hamool Falastini (ينيطسمفلا لوماحلا) in native Arabic (see pictures A, and B). 
The mature plants have no connection to the ground, so it parasites on the host plants. 
The plant has no chlorophyll and cannot make its own nutrients by photosynthesis. 
The stem consists of thread filaments that grow and attach themselves to nearby host 
plants. Cuscuta, is one of the largest and most economically important lineages of 
parasitic plants. The genus has a sub cosmopolitan distribution which is more than 
75% of the species diversifying in the world, the Cuscuta plant included a genus of 
200 species of stem parasites [35].  
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Pictures A and B: Climbing Cuscuta Palaestina parasite, stem and flowers 
respectively. 
 
Cuscuta palaestina is considered one of the most dangerous parasitic plants, causing 
huge losses of various agricultural crops, due to penetrate of leaves and stem of wild 
host plant. Botanical description of Cuscuta palaestina, is leafless plant are 
widespread in the east Mediterranean region like Turkey, Cyprus, Lebanon, Palestine, 
Egypt, Syria, Jordan, Iraq and Iran [36]. It have a flowers 1.5-2 mm, sessile in very 
small, dense head 4-6 mm across; corolla lobes with erect hooded tips. Capsule round 
seeds about 1 mm [37]. The classification of Cuscuta palaestina is shown in the table 
1.  
 
Table 1: Classification of Cuscuta palaestina. 
Kingdom Plantae 
Phylum Tracheophyta 
Class Magnoliopsida 
Order Solanales 
Family  Convolvulaceae 
Genus 
Species 
Cuscuta   
Cuscuta palaestina. 
 
Colorectal cancer develops in the colon or the rectum, also known as the large 
intestine is the third most commonly diagnosed cancer and the third leading cause of 
cancer death in both men and women in the US. The American Cancer Society 
estimates that 136,830 people will be diagnosed with colorectal cancer and 50,310 
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people will die from the disease in 2014 [38]. As part of our efforts to find potential 
sources of natural agents that inhibit cancer development, we have investigated the 
anticancer effects of Cuscuta palaestina crude extract on the colon carcinoma cell 
line. 
According to intensive literature survey, there is no GC-MS method yet reported on 
the simultaneous determination of the phytochemicals present in Cuscuta palaestina. 
The main constituents of the methanol and hexane extracts were explored and 
investigated for the first time by using GC-MS in the electron impact mode. HPLC-
PDA was used to quantitative the active nonvolatile compounds present in Cuscuta 
palaestina extracts by different solvents.  
Since parasitic and hemiparasitic plants are endangered by herbivores and 
microorganisms, they protect themselves by relying on the natural chemical defense 
of the respective host plant, or by mechanical protection (thorns, spines, or 
trichomes). 
 
1.5.2. Gundelia tournefortii plant 
The second plant is Gundelia tournefortii L. (Akoub in English, يمبجلا بوكعلا in 
Arabic) is a spiny perennial flowering plant from Asteraceae (Compositae) family. It 
have rosette leaves, and have purple to yellow flower in spring and early summer (see 
pictures C and D). Gundelia tournefortii thistle is a vegetable, just like artichoke that 
grows in the semi-desert area of many countries in the Mediterranean region 
Particularly in Palestine Iran, Jordan, Syria, Azerbaijan, Armenia, Anatolia and other 
countries. 
 
 
Pictures C and D: Spiny plant of Gundelia tournefortii, and its flowers respectively. 
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The classification of Gundelia tournefortii is shown in table 2. G. tournefortii is an 
important food source and a well-known medicinal plant in Eastern Anatolia. The 
therapeutic effects of medicinal plants are known to be closely related to their 
antioxidant capacities from seed. Traditionally, G. tournefortii is used for treatment of 
hepatoprotective (liver diseases), diabetes, chest pain, heart stroke, gastric pain 
(stomach), vitiligo, diarrhea and bronchitis, epilepsy. It is also reported to have 
hypoglycemic, laxative, sedative, anti-bacterial, anti-inflammatory, anti-parasite, and 
antiseptic [39]. Nature is the best cook factory given the fact that natural products 
have been optimized to interact with the biological systems through a long natural 
selection process [40].  
The traditional recipes to make the akoub are different according to different 
localities. It is mainly prepared by taking the young stems with the head after taking 
off the prickles by a scissor and frying them in olive oil as an omelet, or by adding it 
to meat chops until they are well done. G. tournefortii is still collected wild by local 
Palestinian populations and considered of high market potential because of its health 
benefits reputation [41].  
 
Table 2: Scientific classification of Gundelia tournefortii. 
Kingdom Plantae 
Subkingdom Tracheobionta-Vascular plants 
Superdivision  Supermatophyta-Seed plants 
Division Magnoliophyta-Flowering plants 
Class Magnoliopsida-Dicotyledons 
Subclass Asteridae 
Order  Asterales 
Family Asteraceae-Aster 
Tribe  Gundelieae 
Genus  Gundelia  
Species tournefortii L. 
 
The GC-MS was utilized to explore the potential phytochemicals responsible for the 
anticancer activity. The extracts of this plant was tested for their anticancer activity 
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(human colon cancer cell line). This is the first scientific study to report about the 
potential benefits of consuming wild edible Gundelia tournefortii on cancer and it’s 
phytochemical contents. 
 
1.5.3. Pimpinella anisum plant 
The third plant that is very famous to all Palestinians is the Pimpinella anisum L. 
(Anise in English, نوسنايلا in Arabic). It belongs to Apiaceae (Umbelliferae) family, 
which consists of 300-455 genera and 3000-3750 species globally. Anise is an annual 
herb growing to 30-50 cm with white flower and small green to yellow seed as shown 
in pictures E and F. Anise seed is important natural raw material, which is used for 
pharmaceutics, perfumery, food and drink. It grows in the Mediterranean region, 
Mexico, India, Spain and the Middle East [42]. Table 3 shows the classification of 
anise plant.  
 
Pictures E and F: Pimpinella anisum plant and flower, stem and seed respectively. 
 
Table 3: Scientific classification of Pimpinella anisum. 
Kingdom Plantae 
Order  Apiales 
Family Umbelliferae 
Tribe  Pimpinelleae 
Genus  Pimpinella 
Species anisum L. 
 
P. anisum is primarily grown for its seeds (termed aniseeds) that harvested in the 
period of August and September. The chemical composition analyses showed the 
major components in the aniseeds are p-anisaldehyde, coumarins, scopoletin, 
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umbelliferone, sterol, terpene hydrocarbons, polyenes and polyacetylenes. Essential 
oil mainly contains trans-anethole, phenylpropanoid, and small quantity of estragol, 
 -himachalene, cis-anethol. The pharmacological studies were performed on aniseed 
and demonstrated a variety of therapeutic characteristics such as antimicrobial, 
antifungal, antiviral, antioxidant, inhibition of mucosal damage in stomach, relieving 
constipation alleviating nausea, hypoglycemic and hypolipidemic effects. Anise seed 
used as flavoring and appetizer. It has several therapeutic effects from essential oil 
such as mild expectorant, diuretic, antiseptic, antispasmodic, carminative, relief of 
gastrointestinal spasms. Consumption of anise in lactating women increases milk and 
reliefs their infants from gastrointestinal problems and analgesic in migraine [43]. 
Despite the wide spectrum of pharmacological effects of aniseeds which were proven 
in vitro and in vivo tests, very few clinical studies were performed for evaluating the 
beneficial effects of Pimpinella anisum in human models. In 2013, it has been 
reported that the ethanolic extract of anise seeds exerts significant anticancer effect on 
prostate cancer cell line (PC-3) compared to normal cells (L6 muscle cell line) and 
came to the conclusion that it could be helpful in cancer prevention and treatment and 
may be a natural source of novel anticancer compounds with anti-proliferative and/or 
apoptotic properties [44]. The extraction followed by HPLC-PDA and Preparative-
HPLC were used to fractionate and isolate the most active ingredients in this 
important plant.  Preliminary NMR and MS testing were conducted to determine the 
structure of the active compound present. 
 
1.5.4. Ephedra alata plant 
The fourth plant is the Ephedra alata Decne. (Alanda in English, ةحنجملا ىدنمعلا in 
Arabic), is a perennial genus of nonflowering seed herb, the closest living relative of 
the angiosperm (see picture G) are wild in Palestine. It traditionally used to decrease 
blood glucose and to control blood pressure, as diuretic, and to relief asthma attack, 
and the plant stems are frequently chewed for treatment of bacterial and fungal 
infections. Ephedra alata contains mixture of phytochemical as cardiac glycosides, 
reducing sugars, flavonoid, phenolic compounds and alkaloids [45]. The classification 
of Ephedra alata is shown in the table 4. The Ephedra alata is one of the species in 
Ephedra L a genus of gymnosperm shrubs from Ephedraceae family. The ephedra 
shrub is nearly leafless, jointed with green to brown stems that stands 30.48 cm high, 
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on average but it may grow up to 121.92 cm The various species of Ephedra are 
widespread in many lands, native to north America, southern Europe, northern Africa, 
Arab world region, and the Mediterranean area. Ephedra also known as ma huang, 
used in traditional Chinese medicine to treat asthma or other lung problems [46]. Its 
species contain alkaloids of biological relevance like ephedrine, pseudophedrine, 
norephedrine, norpseudoephedrine (cathine), methylephedrine and 
methylpseudoephedrine. While these effects are usually harmless to healthy 
individuals, caution is needed for those who suffer from heart disease or hypertension 
or diabetes or hyperthyroidism [47].  
 
 
Picture G: The Ephedra alata plants grows wild in West Bank-Palestine.   
 
Table 4: Scientific classification of Ephedra alata.  
Kingdom Plantae 
Division Gnetophyta 
Class Gnetopsida 
Order Ephedrales 
Family  Ephedraceae 
Genus 
Species  
Ephedra  
E. alata   
 
Alanda water extract herb has recently been used to treat bladder cancer which spread 
all over the body of a farmer from Jenin. He returns its importance in preventing the 
spread of cancer cells and their ability to combat cancer of all types. Therefore, the 
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plant was subjected to extraction by methanol, followed by preparative and analytical 
HPLC-PDA to acquire fractionation for biological assay. To study the toxicity for in 
vitro test, screening the crude methanolic extract of E. alata against HepG2 (is a 
perpetual cell line consisting of human liver carcinoma cells, derived from the liver 
tissue). The HepG2 cell line was originally established in 1979 by Barbara Knowles 
and colleagues, and mistakenly reported as a hepatocellular carcinoma [48]. 
 
1.6. Analytical methods for the analysis of plant constituents 
1.6.1. High Performance Liquid Chromatography (HPLC) 
Liquid Chromatography (LC) is the most widely used of all the analytical separation 
techniques. The reasons for popularity of the method are include sensitivity, 
adaptability to accurate quantitative determinations, ease of automation, and 
suitability for separating nonvolatile species or thermally fragile one based on 
differential rates of migration of analytes through a stationary phase by movement of 
liquid mobile phase. Pumping pressures of several hundred atmospheres are required 
to achieve reasonable flow rates with packing of 3 to 10 µm, which are common in 
modern LC. Because of these high pressures, the equipment for HPLC tend to be 
more elaborate and expensive than equipment for other type of chromatography. It's a 
widespread applicability of organic and inorganic substance [49].  
 
1.6.2. Gas Chromatography - Mass Spectroscopy (GC-MS) 
GC-MS is a combination of two different analytical techniques, Gas Chromatography 
(GC) and Mass Spectrometry (MS). GC can separate sample compounds with high 
resolution, While MS can provide detailed structural information on most compounds 
such that they can be exactly identified and quantified [50]. 
 
Gas Chromatography where the volatile or Semi-volatile sample vaporized by 
injection into a heated injector, eluted through a capillary column (stationary phase) 
by inert gaseous mobile phase (carrier gas such as helium or nitrogen) and gradient. 
Temperature and finally detected by detector separation is based on differences in 
boiling points of the solutes and the solutes interaction with the stationary phase 
(compounds with low boiling points elute faster than those with higher boiling 
points). Separated compounds elute from the column and enter a detector, which is 
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capable of creating an electronic signal in response to the presence of a compound, 
the signal size is proportional to the concentration of the compound in the sample.  At 
the end, signal is processed by a computer. 
 
Mass Spectroscopy is an analytical technique that utilizes the degree of deflection of 
charged particles by a magnetic field to find the relative masses of molecular ions and 
fragments. It's a powerful method because it provides a great deal of information and 
can be conducted on tiny samples. Mass spectrometry has a number of application in 
organic chemistry, including determining molecular mass, providing data on isotopic 
abundance [51,52]. A mass spectrometer generates multiple ion from the sample 
under investigation, it then separates them according to their specific mass-to-charge 
ratio (m/z), and then records the relative abundance of each ion type. 
 
Fig. 5 shows schematic of hyphenated GC-MS. It usually consist of single quadrupole 
mass analyzer or ion trap. Normally, it used electron multiplier as detector, and all 
MS systems need ion source, either electron impact (EI) hard ionization, or soft 
chemical ionization (CI-positive or negative),  [53]. 
 
 
 
Fig. 5: Schematic diagram of quadrupole GC-MS. 
 
1.7. Research problem 
In view of the fact that chemotherapeutic drugs are very effective but unselective, 
severe side effects like weakened immune system limit the use of these drugs. People 
have to pay more attention to natural sources as alternatives to treat cancer such as the 
use of plant-derived products that may have reduced adverse side effects [54]. 
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Moreover, plants and other natural sources were for a long time the main source of 
anti-tumor drug candidates [55]. 
 
 
1.8. Aim of the study 
The aim of this study, is to screen four Palestinian plants to assess the antiproliferative 
activity or growth inhibition of various human cancer cell line, to determine the 
bioactive constituent through techniques to know the structures of compounds. 
 
1.9. Objective of the study  
1. Screening of the natural plants, which include Cuscuta palaestina, Gundelia 
tournefortii, Pimpinella anisum, and Ephedra alata crude extracts using 
different solvents and to explore their cytotoxic effect on human colon cancer 
cell line (HCT-166), human prostate cancer cell line (PC-3), and human liver 
cancer cell line (HepG2). 
2. To test the in vitro cytotoxicity for the cancer cells based on the determination of 
EC50 values of the extracts by using the MTT and LDH leakage assay. 
3. To utilize the preparative HPLC coupled with photodiode array detector to 
separate different fractions in the reversed phase mode, and to test the in vitro 
cytotoxic assay of each fraction, then to try to isolate the active pure compounds 
from active fraction along with the assay testing. 
4. To analyze and fully characterize the active compounds by using GC-MS, High 
Resolution-Mass Spectrometry (HR-MS), and 
1
H-NMR. 
 
1.10. Question of the study  
1. What are the main bioactive compounds present in the natural plant, and 
their identities?  
2. What are their biological assay activities in vitro test? 
 
1.11. Hypotheses 
The bioactive compound isolated from natural Palestinian plants affected the growth 
of cancer disease.  
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2. Literature Review 
Cuscuta palaestina Boiss were collected and studied from eastern Crete near Sitia. It 
contained some alkaloids such as sparteine, 11,12-dehydrosparteine, retamine, N-
methylcytisine, cytisine, 17-oxosparteine. These alkaloid were isolated by GC-MS 
[56]. Plants have to defend themselves against herbivores and microorganisms by 
production of chemical defense compounds or allelochemicals [57]. Up to current, 
there are neither data in the literature concerning the analysis of anti-proliferative and 
anticancer activity in Cuscuta palaestina nor chemical composition of their active 
constituents.  
Gundelia tournefortii is a well-known medicinal plant in Eastern Anatolia. 
Antioxidant activities of G. tournefortii, were investigated and the results revealed 
that the seeds have higher antioxidant potential than the aerial parts [58]. The 
Gundelia tournefortii have a physiochemical properties of seed oil content and the 
saponification value of its oil were 22.8% and 166.05 respectively. Oleic and linoleic 
acid content of oil were found 27.99% and 54.59% respectively [59]. Intensive search 
via PUBMED is shown in Fig. 6. There is a noticeable increase in the number of 
publications after the year 2000. Up to current, there is no single report on the effects 
of Gundelia tournefortii extracts against cancer.  
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Fig. 6: Publication trend analysis revealed a sharp increase in scientific publications 
especially after 2000 related to the area of natural product drug discovery. The 
keywords for our search in PUBMED were "Natural/ Products/ Drug/ Discovery". 
The search was done in 13 November 2015. As shown in the figure, the year 2000 
could be the turning point. 
 
However, the effect of Gundelia tournefortii on some biochemical parameters in 
hyperglycemic and hyperlipidemic mice male albino mice were conducted and found 
to induce hyperglycemic and hyperlipidemic by daily injection of dexamethasone 
were the G. tournefortii extract as hypoglycemia and hypolipidemia in 
dexamethasone treated mice [60]. 
The anticancer activity of ethanol extract of anise (Pimpinella anisum) seed was 
investigated. MTT and LDH assays revealed that ethanolic extract have cytotoxic 
activity on human prostate cancer cell line [PC-3] at concentration found safe to 
normal cells (rat skeletal muscle cell line [L6]). Treatment with anise seed extract 
caused anti proliferative and apoptotic effects, with     value of 400µg/ml to cancer 
cell. Thus, anise could be one of the foods that attribute to cancer prevention and 
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treatment. It is worth to assign that anise seeds could contain more than one chemical 
active against cancer cells via targeting, as well to isolate and identification of novel 
anticancer drug candidates from aniseed [44]. 
The essential oil of fruit Pimpinella anisum obtained by hydrodistillation, were 
analyzed by GC-MS. The oil of aniseed was characterized by higher amount of trans-
anethole (96.80%), and the isomer of trans-anethole methyl chavicol (estragol) 0.19%. 
Apart from these two phenylpropanoids, nine sesquiterpenes and one monoterpene 
were present in essential oil of Pimpinella anisum which constituted the other 3.01% 
of essential oil but only γ-himachalene was present with more than 1% [61]. The 
aniseed have anti-microbial activity against Gram positive (Bacillus subtilis) and 
Gram negative (E. Coli) [62].  
Ephedra alata methanolic extract showed that it has high antioxidant activity, and the 
     for the plant was almost equivalent to the Trolox standard antioxidant which 
justified its uses in the Palestinian traditional medicines [45]. The in vitro study was 
conducted and aims to evaluate cytotoxic and cytostatic effects of E. alata water-
ethanolic extract by using MTT assay and LDH assay. The cytostatic activity was 
more potent in co-culture with      of 380 µg/ml against HepG2 cell line, so the E. 
alata traditionally known for anticancer effect [60]. The aerial parts of different 
Ephedra species containing 0.02% to 3.4% of 6 optically active alkaloids, which 
include (-)-Ephedrine, (+)-Pseudoephedrine, (-)-N-Methylephedrine, (+)-N-
Methylpseudoephedrine, (-)-Norephedrine, (+) Norpseudoephedrine were investigated 
[64]. Reliable method was used to determine ephedrine alkaloids and 2,3,5,6,-
tetramethylpyrazine (TMP) in Ephedra sinica by GC- MS [65]. Some Ephedrine type 
alkaloid content was used as nutritional and determined by HPLC from Ephedra 
sinica (Ma-huang) [66]. 
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3. Methodology 
3.1. Materials, and collection Plant 
 Approximately 30 g of Cuscuta palaestina plant, which comprises stems and 
flowers, was collected from farms near the city of Taiba, in the Triangle. The 
specimens were washed with distilled water and dried in the shade (see picture H). 
Supernatant obtained was passed through a 0.2 µm filter for both methanol and 
hexane extract. 
 
 
Picture H: Dried Cuscuta palaestina plant used for extraction in the current study. 
 
 30 g of the aerial parts (stem, leaves and the head) of Gundelia tournefortii were 
collected from the mountains of Nablus (northern Palestine), during February-
March, 2014. The specimens were dried in the shade at room temperature. The 
Pictures below depicts the plant before and after removing its prickles. 
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Pictures I and J: Gundelia tournefortii plant growing wild in Palestine before and after 
removing the prickles. 
 
 Anise seeds were from (Al Alim - Medicinal Herb Center, Zippori), 
approximately 15 g. 
 10 g of Ephedra alata aerial parts were collected in spring and summer 2014 from 
the mountains of Jenin region of West Bank / Palestine. The plants were dried for 
7-10 days in the shade at environmental temperatures. The dried plants were  then 
ground and stored in cloth bags at 5 ˚C until their transfer to the laboratory for 
preparation of the plant extracts.   
 
Picture K: the stem of ephedra collected after dried in shade of the lab. 
 
 The HCT-116 cell line (human colon cancer) were purchased from American-type 
culture collection (ATCC) (Manassas, VA) to be use in the  in vitro test. 
 The MTT dye were purchased from Millipore Cat.# CT02. (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide). 
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 Purchased 50 unit of Cells (2 × 10
4
/well) were plated in 200 µl, and 100 µl of 
medium/well in 96-well plates (corning incorporated, USA). 
 PC-3 cell line (human prostate cancer) were purchased from American Type 
Culture Collection (ATCC) (Manassas, VA) though their representative in Israel, 
Biological Industries Israel Beit Haemek Ltd. The cells were grown in F-12K 
(ATCC) (PC-3 cells) medium, were grown in a humidified atmosphere of 95% air 
and 5% CO2 at 37˚C. 
 The HepG2 cell line (human liver cancer) were from ATCC repository (American 
Type Culture Collection, Rockville, MD, USA), to be use in vitro test. 
 10 mg of sesamin analytical standard (59867-10 MG, P Code 10156745, sigma-
Aldrich). 
 
3.2. Reagents 
 Solvent such as Methanol, Hexane, DMSO, Propanol, Ethanol, Ethyl acetate, 
Chloroform, Isopropanol, Acetic acid, HCl were from Sigma-Aldrich (Jerusalem). 
 Acetonitrile and water are all HPLC grade were from Sigma Aldrich (Jerusalem). 
 The N,O-Bis (trimethylsilyl) trifluoroacetamide (BSTFA) containing 1% 
trimethylchlorosilane used for GC silylation derivatization (>99%, Sigma-Aldrich)  
 
3.3. Instrumentation system 
 Hyphenated GC-MS consists of Agilent Technologies 7890A GC system coupled 
with a mass spectrometer of Agilent Technologies 5975C inert MSD with Triple-
Axis Detector. GC-MS was operated in the electron impact ionization mode (EI) 
at 70 eV.  
 HP7890 gas chromatograph coupled to HP5973 mass spectrometer (electron 
multiplier potential 2KV, filament current 0.35 mA, electron energy 70 eV, using 
the splitless injection mode. An Agilent 7683 auto-sampler was used for the 
samples introduction. A 15 m, 0.32 mm ID 5% cross-linked phenylmethyl 
siloxane capillary column (HP-5MS) with a 0.25 μm film thickness was used for 
separation. 
 Analytical High Pressure Liquid Chromatography (HPLC-PDA) system consists 
of an alliance 2695 HPLC, 2998-Photo diode array (PDA),          software. 
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 Preparative High Pressure Liquid Chromatography (Prep-HPLC-PDA), Empower 
PDA Software, system consists of Water
TM
 600 Controller HPLC (3535 
quaternary gradient module), and Water
TM
 996 Photodiode Array Detector, and 
the Cosmosil Packed column (Code No: 3802401, 5C18-MS-II, Size 20 ID x 250 
mm, Manf. No. K60973) and pre-column (Cosmosil Guard Column, 5C18-MS-II, 
Size 20 ID 20 mm, Manf. No. K62526). 
 
3.4. Equipment's  
 Analytical Balance (Sartorius, accuracy ±0.0001g, Germany). 
 Ultrasonic bath SW12H internal 300 mm x 240 mm x 200 mm (w x d x h). 
 Rotary evaporator RE-3000A was used, 220 V, 50 Hz capacity 1000 ml, receiving 
bottle 1000 ml, speed 20-200 r/min, temp 25 - 90 C
o.
 
 Whatman 6900-2502 GD/X 25 Sterile Syringe Filter, 25 mm, 0.2 Micron, PVDF 
Filtration Medium, Pack of 50. 
 The GC was operated on an Agilent J&W GC column HP-5 column (30 m x 0.32 
mm, id. with 0.25 μm film thickness).   
 Laboratory glassware (volumetric flasks, measuring cylinders, beakers, volumetric 
pipettes, and graduated pipettes).  
 Polypropylene 12 x 32 mm Screw Neck Vial, with Cap and PTFE / silicone 
Septum,100 / pkg.  
 Remedil Disposable syringe 2.5 ml, LOT NO 120308. 
           syringe filters Nylon membrane, diam. 13 mm, pore size 0.2 µm.  
 
3.5. Extraction Methods and analytical procedures 
3.5.1. Cuscuta palaestina plant 
 Procedure of the sample extract and chromatographic conditions 
Cuscuta palaestina: 250 ml of each methanol and hexane were added to the dried 
ground plant material (25 g) after separated  in a tow beakers, and the samples were 
sonicated for 120 minutes at 60 °C, then left in a dark glass bottle for 24 h for 
complete extraction. The methanol extract concentrated by a rotary vacuum 
evaporator under reduced pressure and the hexane extract was evaporated to dryness 
under pressure at 50 °C and dissolved in DMSO for in vitro studies. The dry yield of 
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the extracts was 3.6 gr (14.4%) and 0.46 gr (1.8%) for methanol and hexane extracts, 
respectively. Supernatant obtained was passed through a 0.2 µm filter. 
A 10 mg of Sesamin standard was dissolved in 40 ml of ethanol.  
 
 Calibration Curve of standards 
Sesamin stock solution was prepared by dissolving 10 mg of sesamin standard in 40 
ml ethanol, this brings about 250 ppm solution., The UV-Vis of sesamin was stored  
in the library of HPLC-PDA for matching and quantitation of sesamin in samples., 
Several dilution was made by using the dilution equation      =      to prepare 25 
ppm, 62.5 ppm, 125 ppm and 187.5 ppm., The solutions were filtered using 0.45 m 
membrane filters. The calibration curve was constructed and the linear range was 
determined. The linearity was evaluated by linear regression analysis and the R
2
 value 
was projected. Limits of detection (LOD) and quantification (LOQ) under the present 
chromatographic conditions were determined at a signal-to-noise ratio (S/N) of 3 and 
10, respectively. 
 
 Preparation of extracts from different solvents  
Solution of Cuscuta Palaestina were prepared included 0.9 mg/ml in hexane, 9.7 
mg/ml in methanol, 2.5 mg/ml in ethanol, and 1mg/ml in chloroform. 
 
 Sesamin in Cuscuta palaestina or from host plant. 
Different extracts in methanol with two concentration were prepared as shown in 
Table 5. Five extracts of Cuscuta Palaestina that are parasite on some plants like 
Malva sylvestris (ةزيبخلا in Arabic), Cichorium Intybus (  تِّمع in Arabic), Prosopis farcta 
(توب نَي in Arabic), Portulaca oleracea (  رَبةنيزَب  in Arabic), and unknown X. Another five 
extracts from host plants alone were injected using the same chromatographic 
conditions into analytical HPLC-. 
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Table 5: The concentration of extract in methanol for different plants with Cuscuta 
palaestina as parasite on host plant, and host plant alone. 
No Plant Conc. (mg/ml) Conc. (mg/8 ml) 
1 Cuscuta palaestina + Malva 
sylvestris 
3.9375 31.5 
2  Cuscuta palaestina + 
Cichorium Intybus 
3.275 26.2 
3 Cuscuta palaestina +  
Prosopis farcta 
3.525 28.2 
4 Cuscuta palaestina +  
Portulaca oleracea 
2.7375 21.9 
5 Cuscuta palaestina +  X 
(unknown plant) 
3.8875 31.1 
6 Malva sylvestris 6.4875 51.9 
7 Cichorium Intybus  7.7 61.6 
8 Prosopis farcta 2.5625 20.5 
9 Portulaca oleracea 3.8625 30.9 
10 X (unknown plant) 7.925 63.4 
 
 
3.5.2. Gundelia tournefortii plant 
 Procedure of the sample extract 
The air-dried aerial parts of Gundelia tournefortii were finely powdered. Three equal 
fractions weighting 25 ± 0.01 g of the ground plant was then transferred into 
Erlenmeyer flasks were then extracted with 250 mL of Methanol (  COH), Water 
(H2O) or Hexane (C6H14) solvents. The flasks was then sonicated for 2 h at 50 
o
C, left 
in dark glass bottles for 24 h for complete extraction. The hexane extract was filtered 
and evaporated to dryness under pressure at 50°C and dissolved in DMSO for in vitro 
experiments. The methanolic extract was filtered and dried by a rotary evaporator 
under vacuum. The yield of the extracts was found to be 3.2%, 1.8% and 12% (wt/wt) 
for Methanol, Water and Hexane extracts, respectively. The stock crude extracts were 
preserved in an airtight glass container and kept at -20 °C until use.  
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 Fractionation by Preparative HPLC-PDA 
Eight fractions were collected using prep-HPLC-PDA in order to test it in vitro. 47 
mg extract was dissolved in 20 ml methanol,  1ml of ethanol and 1 ml of acetonitrile, 
shaked well and filtrated fooled by injection to the Preparative HPLC. 
 
3.5.3. Pimpinella anisum plant 
 Procedure of the sample extract 
3 gram of seeds of Pimpinella anisum (anise) was washed with distilled water and 
dried in shade. It was finally grinded to powder then added to 15 ml of methanol in a 
beaker with magnetic stirrer and homogenized for 7 minutes at 50°C. Then left in 
dark glass bottle for 24 h for complete extraction. The extract supernatant obtained 
was passed through a 0.2 m filter, and methanol was evaporated to give 2.5 gram of 
crude extract.  
 
 Fractionation by prep-HPLC-PDA 
One gram of crude Pimpinella anisum was dissolved in 10 ml of 1% acetic acid 
solution (100 mg/ml), and was filtered through 0.45 µm membrane filter before 
injection. One ml of dark clear solution was directly injected to the prep-HPLC and 
six fractions were collected. Evaporate the solvent of each fraction through the rotary 
evaporator. 
 
3.5.4. Ephedra alata plant 
  Procedure of the sample extract   
2 g of the hand grinded of ephedra plant, the material were added to 30 ml of 
methanol and boiled for 7 minutes under stirring. The extract supernatants obtained 
were passed through a 0.2 mm filter, and freeze dried. Take 1000 µg/ml of the crude 
extract for further evaluation for in vitro test. 
 
 
  Fractionation by prep-HPLC-PDA 
25 mg/ml methanolic extract of ephedra plant was directly injected into the prep-
HPLC-PDA.   
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3.5.5. GC-MS analysis conditions for Cuscuta palaestina 
Components of Cuscuta palaestina from methanol and hexane extracts were ran and 
identified by using GC-MS of Agilent Technologies 7890A GC system coupled with 
a mass spectrometer of Agilent Technologies 5975C inert MSD with Triple-Axis 
Detector. The GC was operated on an Agilent J&W GC column HP-5 column (30 m x 
0.32 mm, id. with 0.25 μm film thickness). The carrier gas was helium at a flow rate 
of 1.2 ml/minute and the injection volume was 1l. Injection port temperature was 
300 °C and the ionization voltage was 70 eV. The samples were injected in split mode 
of 10:1. Mass spectral were recorded every 1 second scan over a range set at 45-800 
(m/z).The oven temperature program was started with an initial temperature of 50 °C 
and held for 5 minutes, then ramped to 320 °C with a heating rate of 5 °C/min and 
finally held for extra 20 minutes. The injection port temperature was 280°C and the 
MS interface temperature was 300°C.Solvent delay time was 7 minutes to get rid of 
the gigantic solvent peak. The obtained mass spectra were preliminarily interpreted by 
comparing with the Mass Spectral Library of the National Institute of Standards and 
Technology (NIST, Gaithersburg, USA). 
 
3.5.6. GC-MS analysis conditions for Gundelia tournefortii 
Derivatized samples of Gundelia tournefortii extracts GC-MS analysis were carried 
out using HP7890 gas chromatograph coupled to HP5973 mass spectrometer (electron 
multiplier potential 2KV, filament current 0.35 mA, electron energy 70 eV, and the 
spectra were recorded every second over the range of (m/z) 50 to 800 Da using the 
splitless injection mode. An Agilent 7683 auto-sampler was used for the samples 
introduction. A 15 m, 0.32 mm ID 5% cross-linked phenylmethyl siloxane capillary 
column (HP-5MS) with a 0.25μm film thickness was used for separation. Helium was 
the carrier gas at a constant flow of 1.1 mL/minute. An isothermal temperature was 
first held at 50 °C for 2 minutes, followed by a ramp gradient of 10 °C per minute to 
320 °C and held there for 10 minutes. The total GC-MS run time was 39 minutes. The 
injection port temperature was 220 °C and the MS interface temperature was 300 C. 
Solvent delay time was 8 minutes to eliminate the gigantic hexane and methanol 
solvent peaks. 
Underivatized samples of Gundelia tournefortii Solutions from methanol and hexane 
extracts were ran and identified by using GC-MS of Agilent Technologies 7890A GC 
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system coupled with a mass spectrometer of Agilent Technologies 5975C inert MSD 
with Triple-Axis Detector. The GC was operated on an Agilent J&W GC column HP-
5 column (30 m x 0.32 mm, id. with 0.25 μm film thickness). The carrier gas was 
helium at a flow rate of 1.2 mL/minute and the injection volume was 1 L. Injection 
port temperature was 300 °C and the ionization voltage was 70 eV. The samples were 
injected in the split mode with a ratio of 10:1. Mass spectra were recorded every 
second over a range set at (m/z) of 45-800 Da. The oven temperature program was 
started with an initial temperature of 50 °C and held for 5 minutes, then ramped to 
320 °C with a heating rate of 5 °C/min and finally held for extra 20 minutes. The total 
GC-MS run time was 79 minutes and solvent delay time was 7 minutes.  The injection 
port temperature was 280 °C and the MS interface temperature was 300 °C. 
Identification of the phytochemical components, the percentages of the phytochemical 
components were computed from the GC peak areas by normalization. Library 
searches were carried out using the Mass Spectral Library of the National Institute of 
Standards and Technology (NIST, Gaithersburg, USA) or with mass spectra extracted 
from the literature. 
  
3.5.7. Chromatographic conditions of HPLC-PDA  
3.5.7.1. Analytical HPLC-PDA 
 Method to quantitative of Cuscuta palaestina of standards and samples.  
Chromatographic conditions used to separate and quantify sesamin in Cuscuta 
palaestina.  Crude sample was run on reversed phase ODS column of Waters 
(XBridge, 4.6 ID x 150 mm, 5 μm) with guard column of XBridge ODS (20 mm x 
4.6mm ID, 5 μm). The mobile phase consisted of binary solvent mixture of 0.5% 
acetic acid solution (A) and acetonitrile (B) in linear gradient mode. A 100% A was 
initially used and then descended to 70% A in 40 minutes, then to 40% A in 20 
minutes, finally to 10% A in 2 minutes and stayed there for 6 minutes and then back 
to the initial conditions in 2 minutes. The HPLC system was equilibrated for 5 
minutes with the initial acidic water mobile phase (100 % A) before injecting next 
sample. All the samples were filtered with a 0.45 m PTFE filter.  The PDA 
wavelengths range was from 210-500 nm. The flow rate was 1 ml/min. Injection 
volume was 10 l and the column temperature was at room temperature.   
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3.5.7.2. Prep-HPLC-PDA 
 Method to separation of Gundelia tournefortii sample 
Chromatographic condition used to collect different fraction was a gradient 
combination of eluent A (Milli-Q water); eluent B (acetonitrile). injection volume of 1 
ml. Flow rate was 20.0 ml/min and the gradient elution of the gradient method is 
95.0% A and 5.0% B for 0-2 minutes, then a linear gradient of 95.0% A and 5.0% B 
for 2-18 minutes, then a linear gradient of 0.0% A and 100.0% B for 18-19 minutes, 
then a linear gradient to 0.0 %A and 100.0 % B for 19-20 minutes, then a linear 
gradient to 95.0% A and 5.0% B for 20-22 minutes. 
 
 Method to separation of Pimpinella anisum sample 
The prep-HPLC experiments were run on ODS column (Agilent Prep-HT C18, 22.2 x 
250 mm, 10 μm). The eluent A was highly pure water (Milli-Q) and acetonitrile (B) 
was programmed for a linear gradient starting with 50% A and directly raised to 10% 
A in 18 minutes and stayed there for 1 minute and get back to 50% A in 1 minute,. 
The HPLC system was equilibrated 4 minutes with the initial mobile phase before 
injecting next sample. All the samples were filtered with a 0.45  m micro porous 
filter. Flow rate which was 20 ml/minutes, the injection volume was 1 ml and the 
column temperature was set at room temperature. 
 
 Method to separation of Ephedra sample  
The prep-HPLC-PDA used to run sample of ephedra was by a gradient elution A 
(Milli-Q water); eluent B (acetonitrile). Injection volume was 1 ml  and the mobile 
phase flow rate was flow 15.0 ml/min. The gradient elution was 98.0% A and 2.0% B 
for 0-2 minutes, , then 98.0% A and 2.0% B from 2-20 minutes, then 20.0% A and 
80.0% B form 20-22 minutes, 20.0% A and 80.0% B from 22-23 minutes and then 
returned back to 98.0% A and 2.0% B in one minute. 10µl of Ephedra alata 
methanolic extract was injected into analytical HPLC-PDA. 
 
3.5.8. Cell cultures and treatments  
Cell line HCT-116 (human colon cancer) were maintained as adherent cells in DMEM 
supplemented with 10 percent heat-inactivated fetal bovine serum, 100 IU/mL 
penicillin and 100 μg/mL streptomycin at 37° C in humidified 5% CO2 and a 95% air 
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atmosphere. The medium was refreshed every 2 or 3 days, and HCT-116 cells were 
trypsinized by 0.5 percent trypsin–EDTA when the cells reached 80% to 90% 
confluence. The well-grown cells were harvested and seeded in 96-well plates at a 
density of 2 × 10
4
 cells/200 μL and cultured overnight before treatment. 
PC-3 cells (human prostate cancer cell line). The cells were grown in F-12K (ATCC) 
(PC-3 cells) medium supplemented with 10% fetal calf serum (FCS), 100 U/ml 
penicillin and 0.1 mg/ml streptomycin. All cells were grown in a humidified 
atmosphere of 95% air and 5% CO2 at 37ºC.  
The HepG2 cell line (human liver cancer) was grown in DMEM-5671 medium, with a 
high glucose content  (4.5 g/l), supplemented with 10% vol inactivated fetal calf 
serum (FCS), 1% nonessential amino acids, 1% glutamine, 100 U/ml penicillin, and 
10 µg/ml streptomycin (sigma Aldrich) at 37° C in humidified 5% CO2 and a 95% air 
atmosphere. For the cytotoxic assay, 20,000 cells/100  L medium were seeded in 96-
microplates. 
It is important to mention that all the anticancer part in this thesis was done in a 
collaborative work with Professor Anwar Rayan, Qasemi Research Center, Al-
Qasemi Academic College, Baka EL-Garbiah. 
 
3.5.9. Micro-culture tetrazolium assay (MTT)  
In general MTT colorimetric assays are used extensively in cell proliferation and 
cytotoxicity, which are based upon the bioreduction (reduced by metabolically active 
cell) of a yellow water soluble tetrazolium salt to purple water insoluble formazan by 
mitochondrial dehydrogenase of living cells in which tetrazolium ring gets cleaved in 
mitochondria as shown in Fig. 7. The MTT assay, developed by Mosmann and 
described for the first time by him, depends on the reduction of tetrazolium salt by 
living cells. 
 
Fig. 7: MTT reduced by metabolically active cell to Formazan.   
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Cuscuta palaestina methanol and hexane extracts were added to the cells at increasing 
concentrations (0-1000 μg/ml) by performing the micro-culture tetrazolium (MTT) 
assay [67], based on the capacity of mitochondrial succinate dehydrogenase enzymes 
in living cells to reduce the yellow water-soluble substrate (MTT) into an insoluble 
colored formazan product, which can be measured spectrophotometrically. The 
monolayer cell culture was trypsinized, and the cell count was adjusted using a 
medium containing a 10% fetal calf serum (FCS). After 24 h, when the monolayer 
formed, the supernatant was flicked off, and 100 μl of methanol and aqueous extracts 
were added to the cells in microtiter plates separately and kept for incubation at 37° C 
in a 5 percent CO2 incubator for 24 h, during which time the cells were periodically 
checked for granularity, shrinkage, and swelling. After 24 h, the sample dilution in the 
wells was flicked off, and 100 μL of the MTT dye was added to each well. The plates 
were gently shaken and incubated for 4 h at 37° C in the 5 percent CO2 incubator. The 
supernatant was removed, 100 μL of propanol was added, and the plates were gently 
shaken to solubilize the formed formazan. Absorbance was measured using a 
microplate reader at a wavelength of 620 nm [68,69]. All experiments were repeated 
in triplicates. The effect of the plants extracts on cell viability was expressed using the 
following formula: 
 
 
For Gundelia tournefortii, and ephedra alata the same method of MTT assay was 
adopted,  a cleavage of the tetrazolium ring by succinate dehydrogenase within the 
mitochondria. The formazan product accumulates only in healthy cells. The assay was 
optimized for the cell lines used in the experiments. MTT was applied to assess cell 
viability as described in a previous report [70]. Cells (2 × 10
4
/well) were plated in 200 
µl of medium/well in 96-well plates and were allowed to attach to the plate for 24 h. 
Plant extracts were added at increasing concentrations (0-1 mg/mL) for 22 h. The cell 
medium was then replaced with 100 µl fresh medium/well containing 0.5 mg/mL 
MTT and cultivated for another 4 h darkened in the cells incubator. The supernatant 
was removed and 100 µl isopropanol/HCl (2% HCl (0.1 M) in isopropanol) were 
added per well. The absorbance at 620 nm was measured with micro-titer plate reader 
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(Anthos). Two wells per plate without cells served as blank. All experiments were 
repeated three times in triplicates. The effect of the plants extracts on cell viability 
was expressed using the following formula:  
 
 
The Pimpinella anisum MTT assay is a cell viability test often used to determine 
cytotoxicity following exposure to toxic substances. Cells (2x10^4/well) were plated 
in 100 µl of medium/well in 96-well plates and were allowed to attach to the plate for 
24 h. Pimpinella anisum seeds' extract was added at increasing concentrations (0-1 
mg/ml) for 24 h. The cells medium was replaced with 50 µl fresh medium/well 
containing 0.5 mg/ml MTT and cultivated for another 4 h darkened in the cells 
incubator. The supernatant was removed and 50 µl isopropanol/HCl (1mM HCl in 
100% isopropanol) were added per well. The absorbance at 570 nm was measured 
with microplate reader (Anthos). Two wells per plate without cells served as blank. 
All experiments were repeated three times in triplicates. The effect of the plants 
extracts on cell viability was expressed using the following formula 
Percent of viability = (
                                      
                                          
) * 100% 
 
3.5.10. Silylation derivatization  
One ml of Gundelia tournefortii extracts was taken for each extract was transferred to 
a 2-mL glass vial, and the accumulated solvents were evaporated under a gentle 
stream of nitrogen at ambient temperature. A 150.0 µL of N,O-Bis (trimethylsilyl) 
trifluoroacetamide (BSTFA) containing 1% trimethylchlorosilane reagent used for GC 
silylation derivatization (>99%, Sigma-Aldrich) was added to each dry Gundelia 
tournefortii crude extract followed by heating up to 70 °C for 20 minutes [71]. One 
μL of each derivatized sample was injected into the gas chromatograph (GC) coupled 
with mass selective detector (MS). 
 
3.5.11. Lactate dehydrogenase (LDH) leakage assay  
This is a quantitative colorimetric assay that measures lactate dehydrogenase (LDH), 
a stable cytosolic enzyme that is released upon cell lysis. Released LDH in culture 
supernatants is measured with a 30-minute coupled enzymatic assay, which results in 
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the conversion of a tetrazolium salt (INT) into a red formazan product. All 
experiments were conducted in triplicates. For Cuscuta palaestina extracts take 50µl 
from well plat before added MTT assay, and transfer to another 96-well plate to 
determine the percentage of LDH released in relation to the control was calculated as 
follows: 
 
 
For the Pimpinella anisum the permeability of cellular membranes following the 
exposures was determined by measuring the amount of released lactate 
dehydrogenase (LDH) enzyme from PC-3. Activity of LDH released to the cell 
culture medium was monitored following the formation of formazan by coupled 
enzymatic reaction at 500 nm according to the manufacture kit (CytoTox 96, 
Promega). Cell membrane rupture was defined as the ratio of LDH activity in the 
supernatant of treated cell to the LDH activity released in the control cells. PC-3 cells 
(2x10^4/well) were plated in 50 µl of medium/well in 96-well plates and were 
allowed to attach to the plate for 24 h. After cell attachment (24 h) cells were treated 
with increasing concentrations of the plant extracts (0-1 mg/ml). The extracellular 
LDH activity was measured in the medium after 24 h. Therefore, 50 µl from each well 
was transferred to a new 96 well plate; the enzyme reaction was carried out according 
to the manufacture kit. All experiments were repeated three times in triplicates. The 
effect of the plants extracts on cell viability was expressed using the following 
formula: 
Percent of viability = (
                                      
                                          
) * 100% 
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4. Results and Discussion 
4.1.Cuscuta palaestina plant 
4.1.1. Analysis by GC-MS 
The phytochemical screening using GC-MS methodology revealed 18-components 
identified in the methanol extract of Cuscuta palaestina for the first time. Reasonably, 
less compounds were noticed in the hexane extract. Good resolution was obtained in 
both chromatograms since a 79-minute analysis scan run was adopted ending up with 
a high temperature of 320°C (see the experimental section). This would facilitate the 
elution of high molecular weight compounds out of the capillary GC HP-5 column. 
Figures 8 and 10 show the total ion chromatogram of methanol and hexane extract 
injections respectively. Dodecanoic acid isooctyl ester (20.96%), Palmitic acid 
(10.58%), 2-Fluoro-3-trifluoromethylbenzoic acid, heptadecyl ester (6.7%) and 2-
Fluoro-5-trifluoromethylbenzoic acid, heptadecyl ester (6.88%) are the major 
compounds in the methanol extract. The major chemicals in the hexane extract are 8-
Hexylpentadecane (54.66%), 9-Octylheptadecane (9.33%) and trans-3,4-Dimethyl-2-
pentene (8.42%). The main components along with their retention time (RT) and peak 
area percentages are presented in Tables 6 and 7. Figures 9 and 11 shows the chemical 
structures of the major components in the methanolic and hexane extracts, 
respectively. 
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Fig. 8: GC-MS analysis of methanol extract of Cuscuta palaestina. 
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Table 6: Components of Cuscuta palaestina methanolic extract verified by GC-MS. 
Three phytochemicals namely Sesamin, Campesterol and Stigmasterol are bolded and 
could be the source for the methanolic extract anticancer activity. 
No. Compound name RT (minutes) % Peak Area  
1 Propanoic acid 11.631 2.619 
2 2-Methylbenzaldehyde 17.653 5.376 
3 1-Formylpyrrolidine 19.460 1.754 
4 2-Methoxy-4-vinylphenol 20.298 4.930 
5 1,6-Anhydro-β-D-glucose 24.872 1.543 
6 Hexanoic acid 27.714 1.087 
7 Dodecanoic acid isooctyl ester 35.149 20.965 
8 Palmitic acid 35.273 10.582 
9 (Z,Z)-9,12-Octadecadienoic acid 38.382 1.755 
10 Palmitoleic acid 38.503 3.915 
11 Oleic acid 38.800 1.860 
12 2-Fluoro-3-trifluoromethylbenzoic acid, 
heptadecyl ester 
45.469 6.700 
13 2-Fluoro-5-trifluoromethylbenzoic acid, 
heptadecyl ester 
46.236 6.875 
14 Sesamin 53.502 4.490 
15 ethanone, 2-(3H-imidazo[4,5-b]pyridin-2-
ylthio)-1-(4-morpholinyl)- 
54.172 3.222 
16 Campesterol 54.359 1.449 
17 Stigmasterol 54.689 1.007 
18 Pregn-5-en-3-ol, 21-bromo-20-methyl-, 
(3.beta.)- 
55.429 4.461 
 
Table 6 shows Sesamin compound (4.5%) that may confer antioxidant and anticancer 
effects. Other phytochemicals which belongs to Phytosterols were also noticed but to 
a lesser extent, namely Campesterol (1.5%) and Stigmasterol (1.0%). Phytosterols are 
structurally similar to cholesterol and are validated by their anti-carcinogenic effects. 
For example, Campesterol was stated to act as biomarker for cancer prevention [72], 
and was reported to have potential antiangiogenic action via an inhibition of 
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endothelial cell proliferation and capillary differentiation [73]. Moreover, 
Stigmasterol was reported to significantly inhibit tumor promotion in two-stage 
carcinogenesis in mice [74,75]. Dodecanoic acid isooctyl ester and palmitic acid were 
the dominant compounds demonstrating 20.9% and 10.58% respectively.  
 
 
Fig. 11: Chemical structures of the major components in the methanolic Cuscuta 
palaestina extract. 
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The hexane extract on the other hand was tested for the sake of comparison with the 
polar methanol extract. It shows less number of compounds mainly hydrocarbons 
where 8-Hexylpentadecane was the main principle compound (54.65%) 
 
 
 
Fig. 10: GC-MS analysis of hexane extract of Cuscuta palaestina.  
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Table 7: Components of Cuscuta palaestina hexane extract by GC-MS. Sesamin is 
bolded and could be the source for the hexane extract anticancer activity. 
No. Compound name RT 
(minutes) 
% Peak Area  
1 Trans-3,4-Dimethyl-2-pentene 9.401 8.418 
2 Eicosane 44.622 0.654 
3 Heneicosane 47.610 1.782 
4 Docosane 49.023 0.98 
5 8-Hexylpentadecane 50.409 54.656 
6 11-Butyl-docosane 51.709 1.735 
7 9-Octylheptadecane 52.998 9.326 
8 Sesamin 53.505 1.138 
9 2-(1-adamantyl)ethyl 2-phenylacetate 55.428 2.112 
 
 
 
Fig. 11: Chemical structures of the major components in the n-Hexane Cuscuta 
palaestina extract. 8-Hexylpentadecane is the main principle component (54.65%). 
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Sesamin (Fig. 12) which exists in the oil of Sesame seeds and some other plants, 
exerts a variety of biological activities, including lipid lowering, antihypertensive, 
antioxidant and anticancer effects [76,77,78]. As regards to its antitumor effects, 
Sesamin has already been confirmed to be active against several cancer cell types, 
including breast cancer [79,80], colon cancer [81], and human lung cancer [82]. 
Sesamin could be the major source of the anticancer activity of both extracts of 
Cuscuta palaestina, methanolic and hexane, where it constitutes 4.49% and 1.138% 
respectively. The EC50 values that where measured by the MTT assay may support 
this claim. The values were 71.55 ± 4.75 µg/ml for the methanolic extract and 175.21 
± 3.89 µg/ml for the hexane extract. Show in the Fig. 13, two others Phytosterols 
namely Campesterol and Stigmasterol could also contribute to the bioactivity of the 
methanolic extract of Cuscuta palaestina. Campesterol and Stigmasterol were not 
detected in the hexane extract.  
 
 
 
Fig. 12: Chemical structure of Sesamin phytochemical, potentially responsible for 
anticancer activity in Cuscuta palaestina hexane extract and the major source of the 
methanolic extract activity.   
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Fig. 13: Chemical structure of Campesterol and Stigmasterol phytochemicals found in 
the methanolic extract of Cuscuta palaestina. 
 
4.1.2.  Quantitation of Sesamin in Cuscuta Palaestina samples by HPLC-
PDA 
Fig. 14 shows a typical calibration curve of Sesamin standards including wide range 
of concentrations. An excellent linearity was achieved as the             > 0.999. 
Fig. 14: Calibration curve of Sesamin Compound.  
 
Typical HPLC-PDA Chromatogram of standard Sesamin and its corresponding UV-
Vis spectrum which comprises two wavelengths maxima of 235.5 and 286.4 nm is 
shown in Fig. 15.  
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Fig. 15: Typical analytical HPLC-PDA chromatogram of standard Sesamin at 
concentration of 250 ppm, the UV-Vis spectrum maxima is at λ of 235.5 and 286.4 
nm. 
 
Sesamin was eluted at retention time of 54.609 minutes. 
 
4.1.3. Quantitation of extracted Sesamin using different solvents by HPLC-
PDA 
Sesamin was extracted from Cuscuta palaestina sample using different solvents under 
the same experimental conditions followed by injection to the HPLC.  Retention time 
and PDA-library which contains sesamin standard UV-Vis spectrum was used to 
affirm identity and specificity of the extracted sesamin. Fig 16 portrays the 
chromatographic profile and their corresponding UV-Vis spectrum of the extracted 
sesamin from hexane, methanol, ethanol and chloroform respectively.  Although all 
the chromatograms were recorded at the maximum wavelength (285 nm) to quantify 
sesamin, many other peaks were seen preceding and proceeding sesamin in the 
extracts. 
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D 
 
Fig. 16: Typical analytical HPLC-PDA chromatogram of sesamin peak and their 
relevant UV-Vis spectra (A) hexane extract, (B) methanol extract, (C) ethanol extract, 
and (D) chloroform extract.  
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Table 8: Sesamin concentration and % in different solvent. 
Extract Retention time Area (ppm) Concentration 
(ppm)   
% Sesamin 
A 54.499 175598 6.1 0.68 
B 54.613 625860 21.7 0.22 
C 54.610 308191 10.7 0.43 
D 54.511 116387 9.168 0.53 
 
The PDA stored library matching of peak A, B, C, and D extracts with standard 
Sesamin peak revealed high purity and specificity and therefore possibility of utilizing 
preparative HPLC for scaling up purposes. Methanol showed higher amount of 
sesamin (21.7 ppm) in comparison to other solvents and hexane was the lowest (6.1 
ppm) while sesamin in the non-polar hexane solvent was the best (table 8). 
To prove whether the Sesamin secondary metabolite is endogenous to Cuscuta 
palaestina, or originates merely from the host plant, different samples from the host 
plant alone along with Cuscuta palaestina with the host plant were extracted and the 
sesamin concentration was calculated as shown in Fig. 17. 
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Fig. 17: (A) The chromatogram and UV-Vis spectra of extracted Cuscuta palaestina 
+ Malva sylvestris, (B) The chromatogram Malva sylvestris, (C) The chromatogram 
and spectrum of Cuscuta palaestina + Cichorium Intybus (D) The chromatogram of 
Cichorium Intybus, (E) The chromatogram and spectrum of Cuscuta palaestina + 
Prosopis farcta, (F) The chromatogram of Prosopis farcta, (G) The chromatogram 
and spectrum of Cuscuta palaestina + Portulaca oleracea (H) The chromatogram of 
Portulaca oleracea, (I) The chromatogram and spectrum of Cuscuta palaestina + X 
(unknown plant), (J) The chromatogram of X (unknown plant). 
 
Table 9 shows Sesamin concentration in methanolic extract of Cuscuta Palaestina 
that are parasite to plants (A and C and E and G and I. Since Sesamin peaks were not 
seen in the chromatograms of the host plants, therefore, it was concluded that Sesamin 
is endogenous to Cuscuta Palaestina. 
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Table 9: Sesamin concentration in Cuscuta Palaestina that are parasite on plants.   
Sample Retention 
time (  ) 
Area % Area Concentration 
(ppm) 
A 54.341 86256 100.00 8.174 
C 54.336 59728 100.00 7.301 
E 54.307 94565 100.00 8.448 
G 54.271 21222 100.00 6.033 
I 54.239 40460 100.00 6.666 
 
4.1.4. Anticancer activity of Cuscuta palaestina methanolic and hexane 
extracts 
Cytotoxicity experiments were conducted on Cuscuta palaestina methanolic and 
hexane extracts to disclose the effectiveness of Cuscuta palaestina in cessation of 
tumor growth in cancer treatment. Through the in vitro bioactivity assay, the human 
colon cancer cell line (HCT-116) was exposed to Cuscuta palaestina methanol and 
hexane extracts (0–1000 µg/mL) for 24 h, and cytotoxicity on cancer cell line was 
determined by using the MTT and the LDH leakage assays. The EC50 values obtained 
by the MTT assay was 71.55 ± 4.75 µg/ml for the Methanolic extract and 175.21 ± 
3.89 µg/ml for the Hexane extract. Figures 18 and 19 summarizes results for MTT 
and LDH leakage assays for the Cuscuta palaestina methanol and hexane extract 
respectively. The analysis of the results was carried out using Student’s t-test for 
unpaired two-tailed comparisons; p-values less than 0.05 were considered significant. 
The obtained results indicate that tested Cuscuta palaestina, especially the methanol 
extract has an anti-proliferative activity against human Colon carcinoma cell line with 
significant effect. 
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Fig. 18: MTT (A), LDH leakage (B) assays in HCT-116 (Colon carcinoma, human) 
after exposure to Cuscuta palaestina methanolic extract for 24 h. Data in A and B 
presented as percentage of control (n=3, each value represents the mean of triplicate) 
±SEM; SEM: standard error mean. 
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Fig. 19: MTT (A), LDH leakage (B) assays in HCT-116 (Colon carcinoma, human) 
after exposure to Cuscuta palaestina Hexane extract for 24 h. Data in A and B 
presented as percentage of control (n=3, each value represents the mean of triplicate) 
±SEM; SEM: standard error mean. 
 
4.2. Gundelia tournefortii plant 
4.2.1. GC-MS phytochemical analysis of Gundelia tournefortii 
The phytochemical screening using GC-MS in the electron impact mode (EI) revealed 
70 compounds in Gundelia tournefortii methanolic and hexane extracts, 64 of which 
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are detected for the first time in Gundelia tournefortii. Six anticancer famous 
components, namely, Stigmasterol, β-Sitosterol, Palmitic acid, Linoleic acid, α-
Linolenic acid and Stearic acid were previously reported in the literature [83]. The 
result of GC-MS analysis without derivatization of Gundelia tournefortii revealed 14 
major components in the hexane extracts as shown in Fig.20, and Table 10, and 
Fig.21. 
 
Fig. 20: Total ion chromatogram (TIC) of Gundelia tournefortii hexane without 
derivatization extract. 
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Table 10: Phytochemicals of Gundelia tournefortii from hexane extract by GC-MS. 
No Component name RT (minutes)  % Peak area  
1 Methyl palmitate 35.91 1.89 
2 Methyl linoleate 38.94 1.27 
3 Ethyl oleate 39.06 1.65 
4 NI* 50.39 1.96 
5 Heptadecane 53.01 4.21 
6 Stigmasterol 54.69 5.75 
7 β-Sitosterol 55.44 5.09 
8 α-Amyrin 55.89 5.76 
9 Lupeol 56.45 9.17 
10 Olean-12-en-3-yl acetate 56.95 9.58 
11 Thunbergol 57.49 24.41 
12 Hop-22(29)-en-3.beta.-ol 57.59 11.31 
13 NI 58.45 6.58 
14 A'-Neogammacer-22(29)-en-3-
ol, acetate, (3.beta.,21.beta.)- 
58.58 8.341 
*NI: not identified 
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Fig. 21: Chemical structure of major components in Gundelia tournefortii hexane 
without derivatized extract. 
 
The result of GC-MS analysis without derivatization of Gundelia tournefortii revealed 
13 major components in the methanol extracts as shown in Fig. 22, and Table 11, and 
Fig. 23. 
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Fig. 22: Total ion chromatogram (TIC) of Gundelia tournefortii methanol without 
derivatization extract.  
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Table 11. Phytochemicals of Gundelia tournefortii from methanol extract by GC-MS. 
No Component name RT (minutes) % Peak area 
1 Dodecanoic acid 26.72 5.16 
2 Tetradecanoic acid 31.16 1.58 
3 6,10,14-
Trimethylpentadecan-2-one 
32.89 1.18 
4 (Z)-11-hexadecenoic acid  34.82 2.41 
5 Palmitic acid 35.25 11.70 
6 Linoleic acid 38.45 26.88 
7 (9Z)-9,17-Octadecadienal 38.57 39.28 
8 Artemisinin 42.38 2.39 
9 Matricarin 42.62 1.97 
10 Hop-22(29)-en-3.beta.ol 56.44 2.81 
11 NI* 57.48 1.53 
12 NI 57.58 1.59 
13 Gitoxigenin  58.22 1.51 
*NI: not identified 
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Fig. 23: Chemical structure of major components in Gundelia tournefortii methanol 
without derivatization extract. 
 
Although a satisfactory resolution, selectivity and elution time were obtained on the 
capillary GC HP-5 column, however, the derivatization of the secondary metabolites 
of Gundelia tournefortii seemed to be helpful due to presence of polar 
phytochemicals. Typically, upon deivatization with BSTFA reagent, more volatile and 
stable compounds were generated with amendable properties to GC-MS analysis. We 
noticed a doubled number of sharper peaks culminated, namely 26 peaks in the 
derivatized hexane extracts (Fig. 24, and table 12, and Fig. 25), and methanol extracts 
(Fig. 26, table 13, and Fig. 27). 
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Fig. 24: Total ion chromatogram (TIC) of Gundelia tournefortii silylated BSTFA 
hexane extract. 
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Table 12: Phytochemicals of Gundelia tournefortii from hexane silylated BSTFA 
extract verified by GC-MS. 
No. Component name RT (minutes) % Peak area  
1 3-Methyl-2-butanol 9.33 0.85 
2 1-Methylphenanthrene 9.907 3.14 
3 4-Methylpent-1-ene-2,4-diol 10.17 1.21 
4 D-(-)-Lactic acid  11.18 0.64 
5 Propanoic acid  12.77 0.34 
6 Tetradecanoic acid  16.726 0.51 
7 Cetanol 17.78 1.48 
8 Ethyl icosanoate 18.18 0.58 
9 Tetrandecanioc acid  18.613 5.06 
10 Octadecan-1-ol 19.556 2.2 
11 (E)-3,7,11,15-tetramethylhexadec-
2-en-1-ol. 
19.714 4.68 
12 α-Linolenic acid 20.152 9.38 
13 Stearic acid 20.317 0.95 
14 Oleamide 21.74 1.37 
15 Eicosanoic acid 21.906 0.71 
16 5-Octadecene 22.402 0.51 
17 Di-n-Octylphtalate 22.76 1.99 
18 Tetracosan-1-ol 24.09 1.09 
19 Hexacosan-1-ol 25.414 15.07 
20 Heptacosane 26.39 1.05 
21 Octacosan-1-ol 26.623 9.15 
22 Fructose oxime 27.00 0.49 
23 Stigmasterol  27.599 4.73 
24 -sitosterol 27.95 1.91 
25 12-Oleanen-3-yl acetate 28.791 2.69 
26 Hop-22(29)-en-3beta-ol 29.67 1.97 
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Fig. 25: Chemical structure of major components in Gundelia tournefortii silylated 
BSTFA hexane extract. 
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Fig. 26: Total ion chromatogram (TIC) of Gundelia tournefortii silylated BSTFA 
methanol extract. 
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Table 13: Phytochemicals of Gundelia tournefortii from methanol silylated BSTFA 
extract verified by GC-MS. 
No Compound name RT (minute) % Peak area 
1 DL-Valine 9.2 0.99 
2 Aminoethanol 9.87 0.93 
3 Glycerol 9.99 3.59 
4 L-Isoleucine 10.255 0.45 
5 Succinic acid  10.6 2.2 
6 Glyceric acid 10.75 0.68 
7 Fumaric acid 11.05 0.46 
8 DL-Serine 11.15 0.95 
9 9-Piperidine carboxylic acid 11.198 0.58 
10 Threonine 11.46 0.52 
11 Malic acid 97.21 7.58 
12 L-Aspartic acid 13.151 0.56 
13 4-Amino butanic acid 92.72 4.93 
14 Asparagin 91.11 6.15 
15 Xylitol 15.05 0.28 
16 Arabitol 93.27 1.12 
17 D-Ribofuranose 16.23 3.96 
18 D-Fructose 16.33 5.47 
19 D-Galactofuranose 16.625 0.45 
20 Lyxose 92.9 6.88 
21 Sorbitol 92.17 1.36 
22 Inositol 92.2 5.09 
23 Glucopyranose 90.11 5.01 
24 D-Gluconic acid 90.93 2.61 
25 Palmitic acid 90.89 0.95 
26 Linoleic acid 20.069 0.66 
27 L-Tryptophan 71.923 1.22 
28 Methyl α-D-glucopyranoside 23.23 7.04 
29 D-Xylonic acid 24.17 0.33 
30 Stigmasterol 27.58 0.24 
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Fig. 27: Chemical structure of major components in Gundelia tournefortii methanol 
silylated BSTFA extract. 
 
Sitosterol and stigmasterol were seen after derivatization in the hexane extract (Table 
15, Fig. 28) while stigmasterol alone was seen in the methanolic derivatized extract 
(Table 16). Although there were few active compounds that were seen in both pre- 
and post-derivatization extracts, the more effective phytochemicals were more in the 
underivatized batch. 
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Fig. 28: Six phytochemicals namely (Sitosterol, Stigmasterol, Lupeol, Gitoxigenin, 
alpha-Amyrin and Artemisinin) out of the 70 reported natural components are 
validated as being active against cancerous cells.  
 
Compounds such as sterols, triterpenes, esters and carboxylic acids were seen in the 
Gundelia tournefortii extracts in significant quantities. For example, about 10% of the 
typical sterols, sitosterol and stigmasterol (Fig. 28) were seen in the underivatized 
hexane extract (Table 12). It is reported that sitosterol act as inhibitor of tumor 
promotion in vivo and inhibit carcinogenesis [84,85]. Furthermore, stigmasterol 
significantly inhibit tumor promotion in two-stage carcinogenesis in mice [86]. A 
mixture of sitosterol and stigmasterol was shown to possess anti-inflammatory 
activity after topical application [87]. Therefore, it is expected that the presence of 
such sterols in Gundelia tournefortii would be of paramount importance to combat 
cancer. 
Lupeol (Table 10 and Fig. 19), another phytochemical, which has never been reported 
to be present in Gundelia tournefortii, weighs about 10% in the hexane extract. It has 
been shown to act as a novel androgen receptor, which inhibits the proliferation of 
human prostate cancer cells by targeting -catenin signaling Carcinogenesis [88]. 
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In addition to the aforementioned four anticancer phytochemicals, Gitoxigenin (Fig. 
26 and Table 11) which weighs about 1.5% in the of Gundelia tournefortii methanolic 
extract, was reported to exert significant anticancer activity against renal 
adenocarcinoma and other cancer cell lines with IC50 values in µM range [89]. 
Furthermore, α-Amyrin (Table 10 and Fig. 19) which exist in hexane extract in about 
5.7%, was reported recently to have significant anticancer activity on four cancer cell 
lines (MCF-7, BEL-7402, SPC-A-1 and SGC-7901 cancer cell lines) with IC50 values 
7.2±0.12, 8.2±0.29, 7.6±0.06 and 5.0±0.12 respectively [90]. 
The underivatized methanol extract revealed six carboxylic acids representing 
together about half of the whole extract percentage (48.9%). Artemisinin, an active 
promising photochemical was also noticed for the first time in Gundelia tournefortii 
extract comprising 2.39%. This compound is currently undergoing extensive 
investigation for the treatment of cancer [91]. Moreover, artemisinin was mentioned 
in over than 300 scientific papers as a potential compound in combating cancer. 
 
4.2.2. Gundelia tournefortii methanol extract fractionation by preparative 
HPLC-PDA 
An inch preparative reversed phase C18 column was used to collect as many as 
fractions to test their in-vitro assays. Fig. 29 shows the preparative chromatogram 
along with the UV-Vis of the most active fraction. 
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Fig. 29: Typical preparative HPLC chromatogram of Gundelia tournefortii methanol 
extract at wavelength 232 nm. An overlaid chromatograms at 210 nm (blue) and 232 
nm (black) are shown at the left side of Fig. 27. Fractions retention times: I (2.1-7.4 
minutes), II (7.4-8 minutes), III (8-9.2 minutes), IV (9.2-9.5 minutes), V (9.8-10.4 
minutes), VI (11.6-11.8 minutes), VII (12.6-13.1 minutes) and VIII (13.2-21.1 
minutes). The UV-Vis spectrum of active fraction VIII is located at the right side of 
Fig. 27.  
 
After screening the in vitro anticancer activities of the eight preparative fractions, the 
cytotoxicity of fraction VIII was shown to be the highest against HCT-116 cancer cell 
line. The active fraction (VIII) contains three compounds (Fig. 29). The UV-Vis 
spectra of the 17.540 and 18.607 min eluted compounds possess maximum 
wavelengths of 234.4 and 232.0 nm respectively. The third compound which eluted at 
18.6 minutes showed a maximum wavelength of 316.5 nm (Fig. 29).   
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4.2.3. Anticancer activity of the Gundelia tournefortii methanolic and 
hexane extracts 
The effects of Gundelia tournefortii extracts on human colon cancer cell line (HCT-
116) was determined using the MTT assay. HCT-116 cell line was exposed to 
Gundelia tournefortii methanolic, hexane and aqueous extracts (0-1000 µg/mL) for 22 
hours. The EC50 values obtained by the MTT assay was 303.3 ± 12 µg/mL for the 
methanolic extract and 313.3 ± 18.6 µg/mL for the Hexane extract. However, aqueous 
extract reduced cell viability just to 74.8% at concentration of 1000 µg/mL. Fig. 30-
32 summarize the results of MTT assay for Gundelia tournefortii methanol, hexane 
and aqueous extracts respectively. 
 
 
Fig. 30: Cytotoxic effect of Gundelia tournefortii methanol extract tested on HCT-
116 cell line. HCT-116 cells were seeded in 96-well plate (20,000 cells/well), exposed 
to Gundelia tournefortii methanol extract for 22 hr. Cytotoxicity was determined by 
MTT assay. Each point represents the mean of the data from three independent 
experiments; bars represent the standard mean error (SEM) relative to the control. 
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Fig. 31: Cytotoxic effect of Gundelia tournefortii hexane extract tested on HCT-116 
cell line. HCT-116 cells were seeded in 96-well plate (20,000 cells/well), exposed to 
Gundelia tournefortii hexane extract for 22 hr. Cytotoxicity was determined by MTT 
assay. Each point represents the mean of the data from three independent 
experiments; bars represent the standard mean error (SEM) relative to the control. 
 
 
Fig. 32: Cytotoxic effect of Gundelia tournefortii aqueous extract tested on HCT-116 
cell line. HCT-116 cells were seeded in 96-well plate (20,000 cells/well), exposed to 
Gundelia tournefortii aqueous extract for 22 hr. Cytotoxicity was determined by MTT 
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assay. Each point represents the mean of the data from three independent 
experiments; bars represent the standard mean error (SEM) relative to the control. 
 
Prior to determine cytotoxicity for HCT-116 cell line (human colon cancer), fractions 
(from fraction I to fraction VIII) were evaporated and crude methanolic extract (0.1-
1.3 mg/ml) were exposed for 22 hours to determine the      by the MTT assay. 
Fraction VII is most active as seen from table 14. In the future, further preparative 
chromatography is required to separate about 50 mg of each compounds to run 
biological assays and disclose the identity of the anticancer responsible lead 
compound using 
1
H-NMR, 2D-NMR and HR-MS.   
 
Table 14: The activity of each fraction against HCT-116 cell line. 
Fraction No Viability (% of control) at 0.3 mg/ml 
I 88.36 ± 3.26 
II 87.48 ± 0.35 
III 88.27 ± 4.82 
IV 93.4 ± 2.01 
V 81.5 ± 3.31 
VI 85.74 ± 3.72 
VII 47.45 ± 2.12 
VIII 4.86 ± 0.31 
Methanolic crude extract 35.23 ± 1.8 
 
4.3.Pimpinella anisum plant 
4.3.1. Preparative HPLC separation of Pimpinella anisum extract  
The crude methanolic anise powder was highly soluble upon adding acetic acid to 
water (1%) which may point out for the presence of acidic functionalities in the crude 
mixture. Typical preparative HPLC chromatogram of crude anise and its 
corresponding overlaid UV-Vis spectra between 210-500 nm is shown in Fig. 31. The 
UV-Vis spectra showed peaks having multi absorption maxima’s between the ranges 
of 219 to 342 nm. Six fractions were collected but fraction IV was the predominant 
one. However, the Fig. 33 revealed fraction V was the most pure fraction which upon 
reinjection using analytical HPLC-PDA gave pure peak having multi maxima’s at 
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211.9, 246.2 and 298.5 nm respectively. This fraction proved to possess the highest 
anticancer activity on human prostate cancer cell line (PC-3). 
 
 
Fig. 33: Typical prep-HPLC chromatogram of crude anise. 1000 µl were injected at 
flow rate 20 ml/minutes. The monitoring wavelengths were at 220 (black), 280 (red) 
and 300 nm (blue). Collected fractions: I (1-4 minutes), II (4-6 minutes), III (6-12 
minutes), IV (12-14 minutes), V (15-16 minutes) and VI (16-20 minutes). Overlaid 
UV-Vis spectra of all the eluted peaks are from 210-500 nm is to the left. The active 
peak UV-Vis of the pure fraction V is in right of the chromatogram. 
  
4.3.2. Anticancer activity of the Pimpinella anisum methanolic extract  
The extraction of Pimpinella anisum seeds by methanol, cytotoxicity experiments 
were conducted to reveal effectiveness of consuming anise in cancer prevention and 
treatment. The anise seeds methanolic extract (0-1 mg/ml), used to in vitro test to 
human prostate cancer cell line (PC-3), cytotoxicity was determined using MTT and 
LDH leakage assays as shown in Fig. 34-37.  
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Fig. 34: MTT (A), LDH leakage (B) assays in PC-3 (Prostate carcinoma, human) 
after exposure to anise methanolic extract fraction II for 24 h. Data in A and B 
presented as percentage of control (n=3, each value represents the mean of triplicate) 
±SEM; SEM: standard error mean. 
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Fig. 35: MTT (A), LDH leakage (B) assays in PC-3 (Prostate carcinoma, human) 
after exposure to anise methanolic extract fraction III for 24 h. Data in A and B 
presented as percentage of control (n=3, each value represents the mean of triplicate) 
±SEM; SEM: standard error mean. 
 
0
20
40
60
80
100
120
0 0.2 0.4 0.6 0.8 1 1.2
vi
ab
ili
ty
 %
 
conc. (mg/ml) 
MTT_Anise_fraction III_PC-3 A 
0
50
100
150
200
250
300
0 0.2 0.4 0.6 0.8 1 1.2
%
 o
f 
co
n
tr
o
l  
conc. (mg/ml) 
LDH_Anise_fraction III_PC-3 B 
78 
 
 
 
 
Fig. 36: MTT (A), LDH leakage (B) assays in PC-3 (Prostate carcinoma, human) 
after exposure to anise methanolic extract fraction IV for 24 h. Data in A and B 
presented as percentage of control (n=3, each value represents the mean of triplicate) 
±SEM; SEM: standard error mean. 
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Fig. 37: MTT (A), LDH leakage (B) assays in PC-3 (Prostate carcinoma, human) 
after exposure to anise methanolic extract fraction V for 24 h. Data in A and B 
presented as percentage of control (n=3, each value represents the mean of triplicate) 
±SEM; SEM: standard error mean. 
 
The      values obtained by the MTT assay was 0.5 ± 0.10 mg/ml for fraction II, and 
0.3 ± 0.11 mg/ml for fraction III, and 0.49 ± 0.12 mg/ml for fraction IV, and 0.23 ± 
0.10 mg/ml for fraction V, while the fraction I and VI is not active. Through the 
biological assay, the fraction V is more active than the other fraction.  
1
H-NMR and HR-ESi-MS using the positive and negative modes was ran to the active 
compound from fraction V as seen in the appendix. Preliminary structural elucidation 
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of this compound indicate the presence of high molecular flavonoid compound. 
However, larger amount of this compound followed by silylation and GC-MS analysis 
along with 
13
C-NMR, COSY and HMQC 2D-NMR are needed to be executed to fully 
elucidate the exact structure.  
 
4.4.Ephedra alata plant 
4.4.1. Preparative HPLC fractionation of Ephedra alata extract 
The analytical HPLC-PDA chromatographic profile of Ephedra alata methanolic 
extract at 350 nm is shown in Fig. 38-A. Almost all the main peaks are sharing 
maximum wavelength of 348.5 nm-352.1 nm. These types of compounds are very 
close to isomeric flavonoid glycosides such as symplocoside, kaempferol 3-O-
rhamnoside 7-O-glucoside, isovitexin 2-O-rhamnoside, which may contribute 
significantly to the antioxidant activity and therefore the anticancer of the plant [92]. 
The preparative chromatogram of 1000 l injection of Ephedra. alata methanolic 
extract into inch reversed phase column is shown in Fig. 38-B.  
 
 
 
Fig. 36-A: Chromatograms of flavonoids mixture from methanolic extract of Ephera 
alata at 350 nm. The overlaid UV-Vis spectra of the main peaks are depicted at the 
right corner of chromatogram. 
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Fig. 38-B: Preparative chromatogram of Ephedra alata methanol. The overlaid 
chromatogram at 270 nm (black) and 210 nm (blue) are shown at the right corner of 
the fig. 38-B. The UV-Vis spectra are located at the left corner of the figure. 
 
There are many broad peaks appeared in the chromatogram above. Several fractions 
were collected and their cytotoxicity effect is currently under investigation. 
 
4.4.2. Anticancer activity of Ephedra alata methanolic extract 
Ephedra alata plant methanol extract is prepared to disclose the effectiveness of 
inhibit growth of tumors. The human liver cancer cell-line (HepG2) was exposed to 
Ephedra alata crude methanol extract (0-800 µg/mL) for 24 h, and cytotoxicity was 
determined using the MTT assays. The EC50 values obtained by the MTT assay was 
25 ± 1.2 µg/ml.as shown in Fig. 39. 
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Fig. 39: MTT assays in HepG2 (human liver cancer cell-line) after exposure to 
Ephedra methanolic crude extract for 24 h. Data in A presented as percentage of cell 
viability (n=3, each value represents the mean of triplicate) ±SEM; SEM: standard 
error mean. 
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5.1. Conclusion  
Preparative HPLC-PDA chromatographic fractionation of selected four Palestinian 
plants were successfully achieved and were investigated for their in-vitro anticancer 
activities. To our knowledge, this study is the first to highlight the anticancer activity 
of Cuscuta palaestina and Gundelia tournefortii fractions and pure compounds. Both 
methanolic and hexane extracts have shown considerable anticancer capacity against 
HCT-116 cancer cell. Methanolic extract of Cuscuta palaestina for example exerted a 
significant antiproliferative effect while the aqueous extract of Gundelia tournefortii 
was inactive. GC-MS revealed miscellaneous phytochemicals in methanolic and 
hexane extracts for both plant. Sesamin phytochemical could be the major source for 
the anticancer activity of Cuscuta palaestina extract. The GC-MS and PLC-PDA 
findings advocate that Sesamin content in the methanolic extract of Cuscuta 
palaestina is three times more than that from sesame seed. Two others Phytosterols 
namely Campesterol and Stigmasterol that are well known for their anticancer activity 
were detected in the methanolic extract of Cuscuta palaestina but not in hexane 
extract, while the Gundelia tournefortii contained Stigmasterol in the nonderivatized 
hexane extract and silylated BSTFA methanol and hexane extract alike. Gundelia 
tournefortii showed another potent chemicals such as β-Sitosterol, Lupeol, 
Gitoxigenin, α-Amyrin and Artemisinin which may act synergistically and therefore 
would be of paramount importance to prevent and to combat cancer. The results of the 
current study are coherent with the acquired folk traditional reputation that is 
translated through the survey conducted on participants who are eating Akoub on 
regular basis and believe it to possess anticancer benefits. 
The methanolic extract of anise seeds has also shown a significant anticancer effect 
on human prostate cancer (PC-3 cell line). Thus, anise could be one of the foods and 
drinks (herbal tea) that attribute to cancer prevention and treatment. Preparative 
HPLC of fraction V and its in vitro test showed promising anticancer activity. 
Moreover, Ephedra alata crude methanolic extract has shown antiproliferative 
activity against human liver carcinoma cell line (HepG2). According to the HPLC-
PDA chromatogram and spectra of the major separated peaks of Ephdra alata crude 
methanolic extract, we believe that isomeric flavonoid glycosides may contribute 
significantly to the anticancer activity of this plant. 
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5.2. Recommendation  
The following are some suggestions for future investigations. 
1. Scaling-up sesamin secondary metabolite from Cuscuta palaestina by using 
preparative chromatography to run in-vitro and in-vivo anticancer assays on 
different cell lines and animal models. Moreover, the percentages of sesamin 
from different resources can be explored in comparison to sesame seeds. 
2. Elucidation of the exact structure of the active compound in Pimpinella 
anisum, Ephedra alata and in fraction VIII for Gundelia tournefortii by using 
spectroscopic techniques such as high resolution-mass spectroscopy (LC-
QTOF) and 2D-NMR. 
3. Systematically investigate the synergistic effects of combining different 
fractions and/or diffrent pure compounds from each plant and examining their 
in-vitro and in-vivo assays. 
4. The percentage of the active compounds could be increased by designing 
biotech engineered approaches. 
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Appendices 
 
Appendix 1: 
1
H NMR spectrum of anise pure active V fraction. 
 
Fig. 40: 
1
H NMR spectrum of anise pure active fraction V using 300 MHz, sample 
concentration 10 mg in 2000 µl      .  
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Appendix 2: HR-ESi-MS of anise pure active V fraction using electrospray positive 
mode (+ESi). 
 
Fig. 41: Typical positive electrospray ionization spectrum of anise pure active V 
fraction.  
Appendix 3: HR-ESi-MS of anise pure active V fraction using the electrospray 
negative mode (-ESi). 
 
Fig. 42: Typical negative electrospray ionization spectrum of anise pure active V 
fraction.  
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الكيميائية الموجودة في النباتات الطبيعية لكل من الحامول الفمسطيني، العكوب الجبمي، اليانسون المواد مسح 
 و العمندى المجنحة وتأثيرها الُسمي عمى الخلايا المخبرية
 محمود مخامرةاعداد الطالب: صدام احمد 
 اشراف: البرفسور صالح ابو لافي 
 الممخص
تثبيط نمو الخلايا السرطانية من بعض  منشاط الحيوي فيالبحث ىو التقييم المخبري لاليدف من ىذا 
في  )CLPH-evitaraperp(المستخمصات النباتية وبعض مركباتيا النقية التي تم تحضيرىا بوساطة جياز 
ب الجبمي، اليانسون والعمندى المجنحة. ولقد استخدمت ليذا الغرض تقنيات تحميل الية الحامول الفمسطيني، العكو 
، )SM-CG( ومطياف الكتمة  الغازيةكروماتوغرافيا و ، )ADP-CLPH(متقدمة مثل الكروماتوغرافيا السائمة 
وجية ليذه واستخدمت الفحوص البيول)SM-CL( ، و)RMN-H1(والرنين النووي المغناطيسي لذرة الييدروجين 
 المواد والمستخمصات عمى الخلايا السرطانية لتحقيق ىذا اليدف.
نبات الحامول الفمسطيني مصنف من النباتات البرية الفمسطينية الانتيازية، تم استخدام مستخمصي الميثانول 
مت بإستخدام اختبار واليكسان لتحديد فعاليتو ضد خلايا القولون والمستقيم السرطانية البشرية، النتائج المخبرية ت
 57.4 ± 55.17 )05CE( ، حيث كانت قيمة التركيز الفعال النصفي )HDL(واختبار ال )TTM(ال
مميميتر لمستخمص اليكسان، \ميكروغرام 98.3 ± 12.571و  لمستخمص الميثانول، مميميتر\ميكروغرام
، اما بالنسبة )611-TCH(السرطانية بذل جيد معتبر في تثبيط نمو خلايا القولون بالمستخمص الميثانولي اثبت 
المشيورة والموجودة في زيت السمسم ولكن كميتيا في الحامول  )nimaseS(لممواد الفعالة فيو  فكانت مادة ال
وىذه المادة الفعالة معروفة بقدرتيا عمى  مقارنة عما ىو موجود بالسمسم، اف تقريباعالفمسطيني بمغت ثلاثة اض
اثنين من الاستيرولات ل الضغط العالي ومحاربة السرطان وكذلك تواجد تقميل الالتيابات وتقمي
 وبالتالي يمكن ان يكونوا مصدرا رئيسيا فعاًلا ضد السرطان. )loretsamgitS( و  )loretsepmaC(النباتية
كلات البرية الشوكية شائعة الاستخدام في ويعتبر من الأ شفير ت العكوب الجبمي فيو يشبو الخ ُنسبة الى نبااما بال
المطبخ الفمسطيني. تم التحقق بتأثيرىا المضاد لمسرطان عمى خلايا القولون السرطانية البشرية. وجد أن 
السرطانية بقيمة التركيز الفعال النصفي  )611-TCH(لمستخمصي الميثانول واليكسان فعالية ضد االورم لخلايا 
مميميتر عمى التوالي، بينما المستخمص \ميكروغرام 6.81 ± 3.313مميميتر، \روغرامميك 21 ± 3.303 )05CE(
المائي كان غير فعال. تم التعرف عمى ىوية حوالي سبعين مركب كيميائي نباتي في مستخمصي الميثانول و 
 لمفصولةا  . ستة من ىذه المركباتSM-CGالكروماتوغرافيا الغازية ومطياف الكتمة اليكسان بواسطة جياز 
-α، ninegixotiG، loepuL، loretsamgitS ،loretsotiSتتمتع بفاعمية قوية ضد السرطان وىي 
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من النبات في ثمان  )IIIV-I snoitcarf(. وكذلك تم جمع ثمان اجزاء منفصمة ninisimetrAو  nirymA
يل الذوبان بالماء من وتم الفحص المخبري ليم. اما الجزء الثامن قم )CLPH-evitaraperp(قوارير بوساطة 
 السرطانية   )611-TCH(النبتة فقد وجد ليا الفاعمية الأعمى عمى خلايا
وبخصوص نبات اليانسون  الشيير فمقد وجد لو فعالية قوية ضد السرطان عمى خلايا البروستاتا السرطانية 
 )IV-I morf snoitcarf( لذلك تم فصل وجمع ست اجزاء بكميات كبيرة في ست قوارير  )3-CP(البشرية 
.وكانت قيم التركيز الفعال النصفي التي تم الحصول عمييا كٍل من الاجزاء )CLPH-evitaraperp(باستخدام 
مميميتر، \مميغرام 11.0 ± 3.0مميميتر، \مميغرام 01.0 ± 5.0ىي،  )TTM(، بإختبار الVو  VI، III، II
 ميميتر، عمى التوالي.م\مميغرام 01.0 ± 32.0مميميتر و \مميغرام 21.0 ± 94.0
واخيرا فمقد اكتسبت نبتة العمندى المجنحة مؤخرا سمعة كبيرة بعد استخدام مستخمص السيقان في علاج مرض 
السرطان لمزارع فمسطيني من جنين. ولقد كانت فعالية تثبيط نمو الخلايا السرطانية المخبرية لممستخمص 
ضد خلايا الكبد  )TTM(مميميتر باستخدام اختبار ال \رامميكروغ 2.1 ± 52ىي  )05CE(الميثانولي لمعمندة 
 .2GpeHالسرطانية البشرية 
الأربعة المذكورة سواء  )البرية و المزروعة( الفمسطينية ان ما تم اكتشافو من نتائج ايجابية مشجعة في النباتات
لمزيد من الابحاث لمتوصل الى من المستخمصات او الاجزاء او المواد النقية الفعالة ليدل عمى امكانية إجراء ا
لسرطان ، واىمية دراسة الية عممو وتقييم الفعالية والسُّمية في حيوانات من ا ة لأنواعمضاد ةجديد اتعقار 
 التجارب.
 
